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ABSTRACT

ISOLATION AND CHARACTERIZATION OF MULTIPOTENT LUNG STEM CELLS
FROM p53 MUTANT MICE MODELS

By, Venkat Sundar Gadepalli, M.S (Bioinformatics)
Virginia Commonwealth University, 2009

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of
Philosophy at Virginia Commonwealth University.

Virginia Commonwealth University, 2014

Major Director: Raj R. Rao Ph.D, Associate Professor, Department of Chemical and Life
Science Engineering, Department of Human and Molecular Genetics

Recent advances in understanding lung biology have shown evidence for the existence of
resident lung stem cells. Independent studies in identifying and characterizing these somatic lung
stem cells have shown the potential role of these cells in lung repair and regeneration. While
identifying a homogenous stem cell pool with unique cell surface markers is still a challenge, the
currently available data support the existence of different lung cells with stem cell characteristics
of self-renewal and differentiation. Understanding the functional characteristics of these tissue
resident stem/progenitor cells has gained much importance with increasing evidence of cancer
stem cells, cells in a tumor tissue with stem cell characteristics. Lung cancer is most commonly
characterized by loss of p53 function which results in uncontrolled cell divisions. Incidence of
p53 point mutations is highest in lung cancer, with a high percentage of missense mutations as a
result of tobacco smoking. Certain point mutations in p53 gene results in its oncogenic gain of
functions (GOF), with enhanced tumorigenic characteristics beyond the loss of p53 function.
However, there are no available data on characterization of lung stem cells carrying GOF
mutations and correlating them with those of normal stem cells, in this study, for the first time
we show that percentage of Sca-1 expressing subpopulation is significantly higher in the lungs of
mice carrying p53 GOF mutations than those in lungs isolated from p53+/+ wild type mice.
Additionally, our results show that Sca-1High subpopulations isolated from p53 GOF mutant
knock-in mice possess distinct mesenchymal morphology, higher proliferation and limited
differentiation potential compared to their wild type counterparts. Further, we noted difference in
self-renewal ability, tumorigenic potential, and differentiation ability within the putative lung
stem/progenitor cells isolated from two different p53 GOF mutant knock-in mice.

In the second part of our study, we investigated the role of PDGFR-α as a potential stem cell
marker. We successfully established lung cells differentially expressing two cell surface markers,
Sca-1 and PDGFR-α, with results demonstrating existence of different subpopulations of cells in
the lung. We noted that cells expressing Sca-1Low and PDGFR-α High show no differentiation
capability, suggesting that these cells lack stem cell characteristics. While all other sorted
subpopulations exhibited differentiation potential, Sca-1High/PDGFR-αLow and Sca-1High/PDGFRαHigh subpopulations show more robust differentiation ability and higher proliferation
respectively. These results suggest that incorporation of PDGFR-α as an additional cell surface
marker along with Sca-1 enables us to further identify specific subpopulations with defined stem
cell characteristics. Overall, our findings aide to increase the understanding of lung cell biology,
highlights the need of additional surface markers to identify and isolate more homogenous
stem/progenitor cells, and furthers our understanding of stem cells in the context of lung cancer.

CHAPTER 1: LITERATURE REVIEW

1.1

Adult stem cells

There has been emerging evidence of presence and prospective isolation of somatic stem cells in
various tissues and organs. (Kim et al., 2005; Sherwood et al., 2004; Stingl et al., 2006; Uchida
et al., 2000). Of all the somatic stem cells studied in mouse and humans, the blood forming
hematopoietic stem cells (HSC) were one of the first to be purified and characterized in the
mouse (Spangrude et al., 1988). HSCs have been extensively studied in detail with in vitro and in
vivo studies resulting in invaluable amount of data about their functions and successful clinical
applications (Bryder et al., 2006). The lineage hierarchy of HSCs, from a self-renewing stem cell
to lineage restricted cells, has been well-defined and well-characterized than any other tissue
specific stem cell (Graf, 2002; Weissman et al., 2001)(Figure 1-1). Each cell type in this
hierarchy has been identified with specific or combinations of cell surface markers that define
their phenotype. The HSC reside at the top of the hierarchy and are characterized to be a side
population of cells with higher self-renewal; and multipotent differentiation capability to
generate specialized cells with specific functions. They give rise to multipotent and oligopotent
progenitor cells, characterized by limited self-renewal but, higher proliferation ability. Unlike
1
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HSC, the multipotent and oligopotent progenitor cells possess limited differentiation capability,
which can form 2 or more mature cells within the tissue they reside in. Oligopotent progenitors
constitute common myeloid, lymphoid and other progenitor cells that give rise to mature effector
cells such as erythrocytes, platelets-cells, T-cells, B-cells and other mature blood cells which
exhibit no self-renewal (except memory T and B cell) and limited proliferation. A
comprehensive knowledge on characteristics of each cell type in the HSC lineage hierarchy,
research on their gene expression profiles and mouse transplantation studies has enabled progress
the use of HSCs in clinical applications to treat leukemia blood cancer and other autoimmune
blood cell diseases (Weissman, 2000b; Weissman and Shizuru, 2008; Wilson and Trumpp,
2006). With evidence of somatic stem cells in other tissues, it is important to gain in-depth
understanding of these resident stem cells.

1
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Figure 1-1: Schematic representation of adult stem cell self-renewal
Asymmetric self-renewal properties of somatic stem cells results in a stem cell and a progenitor
cell. The progenitor cells divides repeatedly and give rise to post-mitotic terminally
differentiated cells, thus maintaining homeostasis and stem cell pool of a tissue.

2
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The human body is comprised of about 200 different types of cells with specialized functions
that are unique to the specific tissue or organ in the body. Over the lifetime of a human being,
these cells are replenished as a result of cell death or injury to maintain cell homeostasis in the
body. This is attained by the resident stem cells in response to a stimuli, which by self-renewing
maintains respective stem cell pool of the specific tissue or organ (Slack, 2000; Weissman,
2000a). Few in vivo studies in hematopoietic system suggest development plasticity of these
adult stem cells, an ability to generate differentiated cells beyond their own tissue boundaries
(Korbling and Estrov, 2003). This versatility of somatic stem cells with potential plasticity is
considered a rare phenomenon, which need better understanding and yet to be established across
different tissues (Wagers and Weissman, 2004).

The cell divisions that are most commonly noted in human body are symmetrical, where two
identical daughter cells are formed from a parent cell. This phenomenon is also noted in different
types of cells (e.g., skin cells, lung cells, fat cells, neural cells) that are grown in vitro. However,
these lineage committed primary cells have a limited division capability, which are eventually
replenished by differentiation of respective somatic stem cells. In order to maintain long-term
cell homeostasis during the life time of a human being, it is required that the stem cell pool is
preserved while meeting the specific requirements in a tissue. With the current understanding of
stem cell biology, researchers have noted that this exquisite balance between self-renewal and
differentiation could be achieved by only asymmetric division and are believed to be regulated in
the stem cell niche of the respective tissue (Watt and Hogan, 2000). Two self-renewal strategies
are proposed for these somatic stem cells, population asymmetry and single cell asymmetric
division(Figure 1-2) (Morrison and Kimble, 2006; Shen et al., 2004). In population asymmetry,
3
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the balance between self-renewal and differentiation is attained at the population level, where
some stem cells differentiate resulting in progenitor cells that eventually proliferate to form
specialized cells, while other stem cells go through symmetric self-renewal to maintain stem cell
numbers in the pool. In singe cell asymmetry, the somatic stem cell divides asymmetrically into
a stem cell and a progenitor cell, thus maintaining a constant stem cell pool in the respective
tissue (Klein and Simons, 2011; Simons and Clevers, 2011). It is still unclear if this asymmetry
is regulated by internal (asymmetric segregation of fate determinants during cell division) or
external (stem cell niche) factors. Since, cell division is a complex internal process involving
DNA replication and segregation it is important to maintain high fidelity with no chance for
errors (Fuchs et al., 2004; Ho, 2005). Hence, somatic stem cells are considered to be slowcycling cells and asymmetric division at single cell level supports this view. On the other hand,
lineage tracking studies and development of inducible genetic systems has allowed investigating
population asymmetry in some tissues (e.g., intestinal crypt), with results suggesting that selfrenewal of stem cells follows a stochastic pattern where alongside with single cell asymmetric
division, population asymmetry also exists to maintain tissue homeostasis and stem cell pool
(Shahriyari and Komarova, 2013). However, in-depth understanding of somatic stem cell
division is still an area of active research which requires development of different cellular assays
to monitor cell division both in vitro and in vivo.

4
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Figure 1-2: Schematic representation of two possible somatic stem cell divisions.
Population asymmetry (A) is characterized by differentiation of a stem cell into progenitor cell,
where the loss of stem cell is replenished by a symmetric division of a stem cell in that niche. On
the other hand, Single cell asymmetry (B) is characterized by division of stem cell into two
different cells, a progenitor cell and a stem cell.

5
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The evidence for existence of somatic stem cells has increased over years. Our body is
comprised of various tissues and organs that demonstrate regenerative potential at respective
levels. Some tissues (blood, skin, gut, respiratory tract) are extensively exposed to harsh
environments and hence perpetually replenish damaged cells. While some tissues are poorly
regenerative (e.g., heart, lung) and others are highly regenerative (e.g. liver), various studies have
reported resident stem cells with self-renewal and multipotent capability in different tissue types
(Wagers and Weissman, 2004). These adult stem cells were identified based on expression of
different cell surface markers, some of these markers that have been commonly used are listed (
Table 1.1-1) These differences in regenerative potential are yet to be understood at the cellular
level, but their classification based on potency and tissues of origin provide some insights. The
stem cells are majorly classified based on their differentiation potential, as pluripotent (ability to
generate all body cells, including germ cells e.g. ESC), multipotent (ability to generate all tissue
cells, e.g. HSC), unipotent (ability to generate only single cell type; e.g.: spermatogonial stem
cells). Depending on their tissue of origin/location, differentiation potential, these somatic stem
cells are broadly classified as, epithelial stem cells (e.g. intestinal lining, skin), mesenchymal
stem cells (e.g., bone marrow), hepatic stem cells (liver). However, certain organs like the lung
contain both epithelial and mesenchymal stem cells. In order to understand self-renewal and
differentiation potential of different stem cells, identification and isolation of these cells from
their respective tissue is an important necessity. Even though different research studies have
identified different cell surface markers that correlate with stem cells of respective tissues, these
are not very specific or exclusive for stem cells alone. Some of the cell surface markers that are
employed to identify these specific stem cells are listed in Table 1.1-1 below. There is need for
improved isolation techniques, cell culture protocols and detailed molecular analysis to identify
6
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stem cells with distinct characteristic of self-renewal and differentiation (Barker et al., 2010;
JM., 2000; Ute Bissels, 2013).

7
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Cell surface markers

Tissue/ Organ resident

studied

somatic stem cells reported

References

Bone morphogenetic protein
(Morikawa et al., 2009;
receptor (BMPR)
Bone marrow

Wilson and Trumpp, 2006;

CD34+Sca1+Lin- profile
Zhau et al., 2011)
c-Kit Hoechst dye
Sca-1, c-Kit, CD34

Lung

(Raiser and Kim, 2009)
(Barker et al., 2010; Korbling

Leucine-Rich G Proteinand Estrov, 2003; Morrison
Coupled Receptor 5 (LGR5),

Intestine
and Kimble, 2006; Wagers

BMI-1,
and Weissman, 2004)
Galectin-1, CD133

Neural stem cells

(Shen et al., 2004)

Integrin α6, CD 34

Epidermal stem cells

(Barker et al., 2010)

Table 1.1-1: Commonly studied cell surface markers in identification and isolation of adult
stem cells.
Somatic/adult stem have been studied in a variety of organs and tissues such as bone marrow,
brain, lung, and other epithelial tissues. The table summarized the commonly used cell surface
markers to identify, isolate and establish self-renewing adult stem cells across these different
tissues and organs.

8
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1.2

Stem cells in the lung

The lung is considered to be a highly heterogeneous organ with a variety of cells located in
distinct regions of the organ. Functionally distinct putative stem cells were shown to reside in
different anatomical regions of the respiratory system, which play a key role in repopulating the
cells in their local area (Alamgeer et al., 2013; Hegab et al., 2010; Kajstura et al., 2011; Kim et
al., 2005; Singh et al., 2012). Studies have reviewed the role played by the local stem cells found
in trachea (basal, mucous secretory), bronchus (basal, mucous secretory), bronchiole (clara), and
alveolus (type II pneumocyte) and have shown that they primarily contribute to regeneration of
lost cells/tissues in response to injury (Otto, 2002).

Identification of resident multipotent lung stem cells that can differentiate into any lung cell is
still an area of active research. Two major types of stem cells, namely epithelial and
mesenchymal stem cells have been reported in the lung so far (Hegab et al., 2010; Kim et al.,
2005; Summer et al., 2007). These cells were isolated and characterized based on specific cell
surface markers that are unique to certain cell lineages. In line with the heterogeneous nature of
the lung, the cells that reside in different regions of the lung exhibit differential expression of
various cell surface markers. A classic stem cell marker used in the identification of
hematopoietic stem cells, Stem cell antigen (Sca-1), has also been found to be expressed in some
cells of mesenchymal origin (Holmes and Stanford, 2007). Studies have demonstrated that lung
cells expressing Sca-1 were predominantly found in distal regions of lungs and were shown to
possess a temporal emergence, indicated by enrichment of Sca-1 expressing cells in adult mouse
lungs when compared to neonatal lungs. Sca-1pos cells have been shown to emerge in postnatal
lung during the branching of the airways/lung vasculature and increase exponentially in adult
9
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lungs (McQualter et al., 2009). Based on the expression of Sca-1 and other markers, various
studies have identified unique subpopulations in lung that possess stem cell characteristics
(Raiser and Kim, 2009) . Thus Sca-1 emerged as a representative cell surface marker to identify
the lung stem cells.

Bronchioalveolar stem cells (BASCs) isolated, from bronchioalveolar duct junction in adult
mouse lungs, based on expression of Sca-1 and CD34 (Hematopoietic and epithelial markers)
were shown to exhibit self-renewal and multipotent capabilities. In in vivo studies, the BASCs
were shown to participate in lung epithelial cell renewal and maintain bronchiolar, clara and
alveolar cell populations in the distal lung (Kim et al., 2005). Gene expression analysis on Sca1neg, CD45neg, CD31neg lung populations and corresponding Sca-1pos cell lines were shown to
possess epithelial and mesenchymal gene expression profiles respectively, signifying the
presence of Sca-1pos cells with mesenchymal characteristics (McQualter et al., 2009) (Hegab et
al., 2010). Moreover, the Sca-1pos, CD45neg, CD31neg were enriched with mesenchymal
progenitor cells in culture as shown by their spindle shaped morphology and expression of
mesenchymal markers (CD104a, Vimentin). In contrast, Sca-1neg, CD45neg, CD31neg cells were
shown to possess cobblestone epithelial cell morphology and epithelial marker expression (Ecadherin, cytokeratins 5 and 14, and proSP-C) (McQualter et al., 2009). From a functional
standpoint, the isolated and characterized stem cells in the lung are believed to play an important
role in maintaining lung homeostasis. Bronchiolar stem cells have been functionally defined by
their expression of clara cell secretory protein (CCSP), pro-surfactant protein C and were shown
to reside in airway epithelium (Giangreco et al., 2002; Hong et al., 2001). A systematic study
conducted by Teisanu et al has identified bronchiolar stem cells phenotype as CD45neg, CD31neg,
10
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CD34neg, Sca-lLow AFLow (Teisanu et al., 2009) as opposed to Sca-1pos, CD34pos , , CD45neg,
CD31neg reported earlier by (Kim et al., 2005). Based on studies with transgenic mice models
associated with stem cell expansion, ablation, and lineage tracing, Teisanu and colleagues
demonstrated that CD34pos populations do not belong to the airway epithelium, while CCSP
expressing cells are found in CD34neg, Sca-lLow and AFLow populations (Teisanu et al., 2009). It
is useful to note that evidence of different subpopulations in lung cells with potential stem cell
properties has been attributed to the method of isolation, culturing conditions, and choice of
markers (Raiser and Kim, 2009). These studies indicate the complex nature of lung and presence
of one or more putative stem cells in the Sca-1pos CD45neg CD31neg pool. Details of isolation and
characterization of these cells have been detailed in recent articles published by our group and
others (Gadepalli et al., 2013; Hegab et al., 2010).

In humans, lung stem cells with self-renewing, clonogenic, and multipotent (in vitro and in vivo)
properties were shown to exist. These were identified and isolated based on expression of c-kit in
combination with other cell surface markers (Kajstura et al., 2011). The c-kitpos cells were
negative for hematopoietic and mesenchymal markers and interestingly demonstrated positive
expression of key markers associated with pluripotency: OCT4, NANOG, KLF4, and SOX2.
However, a key defining feature of somatic stem cells that differentiates them from pluripotent
stem cells is that they undergo asymmetric division that results in the generation of a
heterogeneous population of stem cells and progenitor cells. This study has been received with
some skepticism putting forward several questions and need for independent studies to ascertain
existence of somatic lung stem cells in humans (Stripp BR, 2011).
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The fact that lung tissue is composed of a variety of cells with distinct phenotypes and functions
complicates our understanding of lung regeneration. This is evident from multiple research
studies where lung cells characterized by different markers were shown to possess core stem cell
properties of self-renewal, clonality, and multipotent characteristics (Hegab et al., 2010; Kim et
al., 2005; Raiser and Kim, 2009). While these research studies promise a step ahead in
identifying putative lung stem cells, there are challenges that need to be addressed. One such
challenge is to define a unique set of cells that possess multipotent capability as well as play a
crucial role in lung regeneration. This is not only expected to strengthen our attempts to develop
focused therapeutic strategies in the context of wound healing but also in identifying and
targeting putative cancer stem cells in the lung. Some of the studies carried out in identifying
lung stem cells in mouse and their characteristic features described by experimental evidence are
summarized in Table 1.2-1.
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Anatomical location
Markers for sorting

Comments

Reference

of cells
These cells were
Sca1pos, CD34pos,

Bronchi alveolar duct

positive for clara cell

CD45neg, CD31neg

junction

marker and Surfactant

(Kim et al., 2005)

protein marker.
Similar to other
Sca1 expression is
mesenchymal
predominantly found
Sca1pos, CD44pos,

progenitors, these
in Distal Lung,

pos

(Holmes and

neg

CD106 , CD45 ,

cells express Sca-1,
restricted to

Stanford, 2007)

neg

CD31

CD106, CD140a
Endothelial and
(PDFGR-a) and
Perivascular Cells
CD44.
Differentiated into

Sca1pos, CD45neg,

endothelial and lung
-

(Hegab et al., 2010)

CD31neg

epithelial (alveolar
type I, II, and clara)

Table 1.2-1: Cell surface markers studied to identify adult lung stem cells.
The above table summarizes cell surface markers employed across different research studies to
identify and isolate somatic/ adult stem cells in the lung. It also highlights the anatomical
location and specific characteristics of lung subpopulations that these studies have established by
using a combination of different cell surface markers.
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1.3

Lung cancer

One of the leading causes of cancer-related deaths is cancer of the lung, of which 80-90% is
attributed to tobacco smoking (Ferlay J, 2013; Jemal et al., 2011). More than 50 different
histological variants of lung cancer have been recognized by the World Health Organization
(WHO) and classified based on their phenotype, their zone of origin in the lung, or by tumors
arising from functionally diverse lung cells (Travis, 2004). This diversity characterizes the
neoplasms in lung as heterogeneous with different histological subtypes. Almost 98% of lung
cancers are carcinomas (tumors arising from epithelial cells) and based on the size of a cancer
cell, categorized as small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC)
carcinomas. SCLCs and NSCLCs constitute approximately 10-15 % and 85-90% of lung cancers
respectively (Travis, 2002, 2011). The SCLCs are malignant small epithelial cells with scanty
cytoplasm. The NSCLCs are further classified based on their size and shape as large cell
carcinoma, squamous carcinoma, and adenocarcinoma. NSCLCs are relatively larger in size and
contain a high nucleus to cytoplasmic ratio (Travis, 2002; Travis, 2004; Travis et al., 1995).
Additionally, other rare subtypes of lung cancer include bronchioalveolar carcinoma, carcinoid,
glandular, and neuroendocrine tumors.

According to NCI PDQ®, of all the subtypes in lung cancer, the incidence of squamous and
adenocarcinoma are considered to be the highest (NCI, 2014). Studies comparing the major four
subtypes of lung cancer recognized that the rate of development of adenocarcinoma is more
common and constitute approximately 40% of these lung cancer subtypes in humans, with the
cause strongly associated with tobacco smoking (Kenfield et al., 2008; NCI, 2014; Travis, 2004).
Various other factors such as asbestos, arsenic, radon (radioactive gas formed as a result of
14
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breakdown of uranium in soil), and environmental air pollution also pose a risk of lung cancer
(Subramanian and Govindan, 2007). Epidemiological studies and molecular biology studies have
indicated a high risk of at least 20 carcinogens in tobacco smoke that can cause lung cancer
(Hecht, 1999). Research has shown that tobacco carcinogens such as polycyclic aromatic
hydrocarbons (benzo[a]pyren) target hot spots in codon regions of TP53 by forming DNA
adduct, thus forming sites for mutations in cancer (reviewed and summarized in (Toyooka et al.,
2003)). The systematic analysis based on different lung cancer research data uploaded at
International Agency for Research on Cancer (IARC) indicates a moderate relationship between
smoking exposure and mutation pattern in codon regions (157, 158, 175, 245, 248, 249 and 273)
of TP53, suggesting that mutational pattern in cancers arising in smokers is not specific to a
single codon. Studies also confirmed a high frequency in G: C to T: A transversions in TP53
coding region of smokers (16%) than in non-smokers (5.8%). One key observation in their
analysis is change of mutational spectrum based on gender. For instance, G: C to T: A
transversions found to be higher in female smokers (36%) than male smokers (27%) (Ezzati et
al., 2005; Toyooka et al., 2003). The advances at molecular level in understanding the cause of
cancer and research studies targeting identification of cancer stem cells hold promise for
development of novel approaches in diagnosis and treatment of lung cancer.

1.4

Cancer stem cells in the lung

Over the past few decades, advances in cancer research have enabled us to understand the
different mechanisms that contribute to the aberrant proliferation of normal cells into abnormal
cells that result in tumors. In the pursuit to find cures, researchers have primarily focused on
various molecular level changes that are unique to cancerous cells. In humans, about 50% or
15
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more cancers have a mutated tumor suppressor p53 gene thereby resulting in accumulation of
p53 protein and losing its function to activate the target genes that regulate cell cycle and
apoptosis. Extensive research conducted in murine cancer models with activated p53, loss of
p53, or p53 missense mutations has facilitated researchers to understand the role of this key
protein. In spite of identification of numerous triggers that cause cancer, specific cures still
remain elusive. One of the primary reasons attributed to this is due to the fact that the tumor
tissue is heterogeneous and contains numerous subpopulations of cells. Studies have shown that
a specific subpopulation of cells termed as cancer stem cells (CSCs) drive the recurrence of
cancer in response to standard chemotherapy. These CSCs are mutated cells with core properties
similar to those of adult stem cells. They reside in a microenvironment within the tumor tissue
that supports their growth and make them less susceptible to drug treatment. These cells possess
properties of self-renewal and migration, thereby driving tumor formation and metastasis. Over
the last decade, research specifically targeting these cells has gained prominence towards
developing new therapeutic agents against cancer.

Numerous studies have demonstrated the presence of subpopulations of cells in tumors that play
a critical role in initiating a tumor during post chemotherapy or radiation treatments (Alamgeer et
al., 2013; Perona et al., 2011). These cells are present as a small population within the tumor and
appear to be more potent in initiating the tumor than other subpopulations and have been
classified as cancer stem cells (CSCs). These CSCs were characterized by independent research
studies and were shown to sustain their malignant phenotype against drugs targeting cancer
(Berns, 2005; Kratz et al., 2010; Perona et al., 2011). Interestingly, these CSC subpopulations
were found to possess stem like properties of self-renewal and differentiation similar to those
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exhibited by somatic stem cells. Certain signaling pathways such as Hedgehog, Notch, and WNT
that are important for maintenance of embryonic stem cells were also shown to have a role in
putative CSCs found in the lung (Hassan et al., 2013; He et al., 2005; Singh et al., 2012; Zhang
et al., 2013; Zhang et al., 2012). Thus the discovery of CSCs has opened a new area of research
in cancer that focuses on understanding and targeting the cells that drive the recurrence of tumor
and metastasis.
CSCs share similarities with the resident somatic stem cells in their respective tissues of origin.
Somatic stem cells are characterized by their oligopotent property, where they continuously
renew themselves as well as differentiate into distinct descendants that are specific to a tissue.
Somatic stem cells are found along with specialized cells of an adult tissue or organ as rare side
populations. For prolonged periods of time they reside in quiescence (G0/resting) phase of the
cell cycle, a stage that is an actively controlled phase involving various epigenetic,
transcriptional, and signaling pathways (Cheung and Rando, 2013). In response to injury or
stimuli, these somatic stem cells enter mitosis and give rise to a stem cell and a progenitor cell by
the process of asymmetric cell division. The stem cell resides back in quiescence stage until the
next signal to re-enter the cell cycle, while the progenitor cells undergo a series of amplifications
that give rise to post mitotic differentiated cells in respective tissues or organs of an animal. This
characteristic asymmetric division not only plays a role in maintaining homeostasis in adult
tissues by replacing the dead or aging cells, but also avoids repetitive entry of stem cells into the
cell cycle, which may increase the chance of DNA damage. This similar kind of hierarchy is
observed in CSCs, where a side population of cells forms the backbone to drive relapse of tumor
and metastasis. However, unlike normal somatic stem cells these CSCs possess abnormal
characteristics which are currently being explored in the context of understanding their role in
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specific cancers. A broad perspective and future directions in identifying cancer stem cells, in
vitro and in vivo assays to characterize them, and developing drug screening strategies have been
critically discussed (Beck and Blanpain, 2013; Clarke et al., 2006; Liao et al., 2014).

Identification and isolation of these CSCs from the bulk of tumors have been reported based on
presence of specific markers that differ from those used to identify adult lung stem cells have
been recently reviewed (Alamgeer et al., 2013). The phenotypic characterization of CSCs
include the activity of cytoplasmic enzyme aldehyde dehydrogenase (ALDH)(Jiang et al., 2009),
expression of cell surface markers CD133 and CD44, or capacity of cells to efflux membrane
permeable dyes such as Hoechst 33342 dye and existing as a side population (SP) in bulk of
tumor cells (Ho et al., 2007). CD133 has been identified to be a putative marker for NSCLC and
SCLC, while CD44 is found to be enriched only in NSCLC and not in SCLC. Similarly, NSCLC
demonstrate positive activity for ALDH. (Chen et al., 2008). Identifying a panel of universal
markers to classify CSCs is an active area of research. Signaling pathways such as Hedgehog
(Hh), Notch, and WNT are important in the maintenance of stem cells and tissue homeostasis are
also found active in CSCs(Alamgeer et al., 2013). It is believed that dysregulation of these
pathways in CSCs could drive their tumorigenic activities with several reports focused on
developing therapeutic strategies to target these pathways. For example, inhibiting Hh signaling
pathway in lung cancer cell lines resulted in loss of side population cells, while targeting Notch
and Wnt signaling resulted in reduction of ALDH positive tumor cells or induction of apoptosis
or growth inhibition in NSCLC (He et al., 2004; Sullivan et al., 2010; Tian et al., 2012).. These
clinical trials provide some novel developments in treating lung cancer but further trials are
needed to demonstrate efficacy. Despite these encouraging clinical results in treating cancer,
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other mechanisms that are being discovered in CSCs still need to be further researched to
develop feasible therapies. One such key mechanism is the Epithelial-mesenchymal transition
(EMT) in CSCs, first reported in breast cancer stem cells (Mani et al., 2008), where the CSCs
were shown to exploit this EMT mechanism that is normally observed during developmental
process of the mesoderm. It involves a process by which the epithelial cells lose their
morphology and gain migratory and invasive properties to become mesenchymal cells. This
EMT mechanism was found to be activated during cancer invasion and metastasis and results in
the generation of mesenchymal cells that express the stem cell marker CD44 and form tumors
effectively in mammary epithelial cancer cells (Mani et al., 2008) and believed to be associated
with drug resistance and cancer progression. Our current understanding is limited on signaling
pathways and transcriptional factors that takes place in these CSCs. Expression of EMT
associated genes is also being assessed in the context of lung cancer, but the role of EMT in
progression of lung cancer is yet to be established (Xiao and He, 2010).

1.5

Lung cancer and role of tumor protein p53

In normal cells, p53 is expressed at low levels but as a result of stress or cellular damage, it
activates a host of different proteins that are involved in cell cycle, apoptosis, and senescence,
thereby preventing proliferation of cells that carry mutations or DNA damage. In unstressed
cells, p53 function is regulated by its specific target murine double minute 2 (MDM2) by a
process of ubiquitination. MDM2, an E3 ubiquitin-protein ligase, binds N-terminal
transactivation domain of p53, thus mediating p53 degradation by nuclear and cytoplasmic
proteasomes. This constant mono-ubiquitination by MDM2 regulates physiological levels and
functions of p53 in normal cells (Moll and Petrenko, 2003). Apart from known functions of p53,
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recent evidence suggests that p53 plays a crucial role in regulating stem cell homeostasis
(Bonizzi et al., 2012). Studies involving re-programming of differentiated cells into induced
pluripotent stem cells have noted that inhibition or loss of p53 increases the reprogramming
efficiency by 3 to 10 fold (Kawamura et al., 2009; Li et al., 2009; Marion et al., 2009). These
studies indicate that p53 has a pivotal role in restricting the reprogramming process. Other
studies involving adult mammary stem cells derived from p53-/- mice were shown to possess
immortal behavior by increased self-renewal and symmetric division as opposed to limited selfrenewal and asymmetric division observed in their wild type counterparts (Cicalese et al., 2009).
Similarly in hematopoietic stem cells (HSC), expression of p53 has been found to be critical for
regulation of several aspects of HSC behavior. Deletion of p53 in mice was also shown to
contribute to increased HSC self-renewal as well as an increase in the HSC pool (Liu et al.,
2009). In HSCs, p53 was also found to regulate cellular response to oncogene expression in
progenitor cells, where absence of p53 and expression of proto-oncogene KRAs was found to
promote acute myeloid leukemia (Zhao et al., 2010). A recent study in hematopoietic stem cells
and mammary stem cells has noted that DNA damage by irradiation induces up regulation of
p21, a known target of p53 , thereby impeding apoptosis , cell cycle progression with symmetric
cell divisions (Insinga et al., 2013). These studies indicated that elevated levels of p21 prevent
p53 activation and its basal activity, thus preventing stem cells from apoptosis, and allowing
them to enter the cell cycle. This study identified a unique mode of p21-dependent response to
DNA damage in stem cells wherein p21 activates DNA repair, minimizing DNA damage
accumulation, and exhausting the stem cells to divide symmetrically as opposed to less stressful
asymmetric division (Insinga et al., 2013). In summary, these studies suggest that, apart from its
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normal functional role in tumor suppression and cell cycle regulation, p53 is able to restrain adult
stem cell self-renewal, and impose asymmetric mode of cell division.
The loss of tumor suppressor function of p53 is either impaired by deletion of Tp53 gene or
expression of mutated p53 protein. Alternatively, in some human cancers even though wild type
p53 is active, its function is diminished by its primary cellular inhibitor, MDM2. These
functional disparities are the most commonly observed causes of cancers in humans. MDM2 has
a dual function towards p53, by acting as a positive regulator of p53 by interacting with p53
mRNA when the ATM (Ataxia telangiectasia mutated) pathway is active. As the ATM activity
ceases, MDM2 acts as a negative regulator to suppress the p53 protein activity by mediating its
degradation under normal conditions (Gajjar et al., 2012).

The incidence of p53 missense mutations (70%) is highest in lung cancer compared to all cancer
types. Approximately 90% of these p53 mutations are missense mutations that result in
accumulation of mutant p53 protein (Govindan et al., 2012; Govindan R, 2014). These impact
molecular activity of cells and cause novel tumors not commonly observed in p53-/- (p53 null)
cancerous mice. These missense mutation effects have been explained based on two primary
models: dominant negative (DN) activity or oncogenic gain-of-function (GOF) (Olive et al.,
2004). In the first model, it is proposed that the mutant protein forms a hetero tetramer with wild
type p53 and exerts a dominant negative effect on wild type p53 function. In the second model, it
is projected that the mutant allele confers oncogenic progression irrespective of the wild type p53
allele counterpart. Studies carried out to understand the GOF mutations by transforming p53 null
mice with mutant p53 constructs have supported the effects based on the GOF model.
Phenotypic characteristics ascribed to GOF activity of mutant p53 include increased
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tumorigenicity, growth rate, motility, metastasis, invasiveness and decreased sensitivity to
chemotherapeutic drugs (Olive et al., 2004). Understanding the changes in these cancer lines
with GOF activities is basically proposed as an important area of research for drug targeting.
Towards use in these studies, many researchers have generated p53 mutant mouse models (Olive
et al., 2004) and human cell line models based on mutations reported by research studies
complied in IARC TP53 database (http://www-p53.iarc.fr/). Recent studies have also highlighted
the use of lentiviral approaches (endogenous expression) or transfections (transient expression)
to express tumor-derived mutant p53 in cells (Vaughan et al., 2013).. It is observed that these
p53 mutants show enhanced expression of NF-kappaB2 and receptor tyrosine kinase AXL (Scian
et al., 2005; Vaughan et al., 2012b) that could be potential targets for therapies. However,
mechanisms underlying these differential expression are unclear and yet to be defined.
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Figure 1-3: Schematic representation of conditional point mutations in p53 gene exons
In this study, 2 different types of p53 point mutations expressing mice and a p53+/+ wild type
mice were employed. The targeting vector were constructed by specific mutations in the codon
region of endogenous p53 at exon 5 for p53R172H/+ and at exon 2 and 5 for p53QSH/+ (red color).
To induce stage specific expression lox-Stop-lox (LSL) element (yellow color) is introduced in
the intron location.
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Figure 1-4: Schematic representation of point mutations in p53 protein domain structure
Point mutations in the expressed p53 protein of the respective mice carrying the engineered p53
constructs are represented above. The targeting vector carrying p53R172H/+ mutation express a
point mutation in the DNA binding domain of the p53 protein, where arginine is replaced by
histidine at position 172 (represented by red line). Similarly, the targeting vector carrying
p53QSH/+ mutation express point mutations in the transactivation domain and DNA binding
region of the p53 protein, where glutamine is replaced by leucine and tryptophan is replaced by
serine at positions 25,26 and arginine replaced by histidine at position 172.
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1.6

Summary

Cancer stem cells are found to conserve many properties of normal somatic stem cells that relate
to self-renewal and differentiation. Some of these mechanisms, specifically related to selfrenewal and differentiation are defining features of somatic stem cells. Along with stem-cell like
characteristics, CSCs also carry dysregulated activities in of p53, MDM2 and pathways
dependent on these proteins. They develop resistance to the action of drugs by activating new
molecular mechanisms and thereby prevent apoptosis. It is thus important to understand protumorigenic effects of missense mutations and their impact on cancer progression.
Understanding the molecular mechanisms that lead to tumorigenic properties of CSCs will
enable us to develop effective therapeutic strategies.

With the available data on lung stem cells, it is reasonable to expect that Sca-1 positive and
lineage negative lung cells possess stem cell characteristics of differentiation and self-renewal.
As discussed in this chapter, identification of homogenous lung somatic stem cells is still an
active area of research. It is thus important to establish homogenous population of lung stem
cells to understand their unique characteristics. Based on the background evidence, we propose
to investigate the following specific aims.
Specific Aim (I) Comparison and correlation of Sca-1 expressing lung stem/progenitor
cells across p53 normal and cancer-sensitized p53 mutant mice
Experiments under this specific aim are focused to investigate the phenotype, functional and
tumorigenic properties of Sca-1 expressing and lineage negative lung cells across p53 normal
and cancer-sensitized p53 mutant mice backgrounds.
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Specific Aim (II) Isolation and characterization of lung stem/ progenitor cells based on
Sca-1 and PDGFR-α
Experiments under this specific aim are focused to investigate the phenotype and functional
differences of lung cells that are lineage negative but, differentially express Sca-1 and PDGFR-α
cell surface marker. We will characterize these sub-sorted populations for their multipotent
ability. These results will aide us in determining the role of PDGFR-α as a potential lung stem
cell marker.
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CHAPTER 2: COMPARISON AND CORRELATION OF SCA-1 EXPRESSING LUNG
STEM/PROGENITOR CELLS ACROSS P53 NORMAL AND CANCERSENSITIZED P53 MUTANT MOUSE MODELS

2.1

Abstract

Incidence of p53 point mutations is most common in lung cancers that result in oncogenic gain
of function (GOF). Tumor recurrence after initial treatments in cancer patients is attributed to
presence of cancer stem cells. The role of cancer stem cells in lungs is still an area of active
research. In this study, we characterized lung stem/ progenitor cells from cancer sensitized mice
carrying p53 GOF mutations. Our results show that there is distinct morphological and cell
proliferation difference between the Sca-1 expressing cells established from mice lungs carrying
different p53 genotypes. Additionally, our results suggest that Sca-1 expressing subpopulation of
cells are significantly higher in p53 mutant carrying mice lungs than those in p53+/+ wild type.
We also noted that Sca-1 expressing p53 mutants show tumorigenic properties of p53
accumulation, migration, and colony formation in non-adherent culture conditions. When the
cells across the different genetic backgrounds were subjected to mesenchymal lineage
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differentiation, we noted that Sca-1High p53+/+ wild type readily differentiated into adipogenic
and osteogenic lineages. However, the mesenchymal differentiation ability of the cells isolated
from p53 mutants is not evident compared to their wild type counterparts. Results from our
studies demonstrate the stem cell and tumorigenic nature of Sca-1 cells carrying p53 GOF
mutations. This study lays the foundation and rationale for elaborate cellular and molecular level
investigation of resident stem/progenitor cells expressing p53 GOF mutations. The insights on
these resident stem/progenitor cells will ultimately shed light on cancer progression and
development of new therapeutics in treating lung cancer.

2.2

Introduction

Cancer is a complex disease condition which results in uncontrolled division of affected cells. It
is caused by combinatorial or discrete events of genetic changes (Govindan et al., 2012),
environmental exposure to chemicals and radiations (Gorlova et al., 2006; Subramanian and
Govindan, 2007), or life style choices, such as smoking (Hecht, 1999; Travis, 2004). According
to recent estimates of incidence and mortality rates obtained by the International Agency for
Research on Cancer, lung cancer was the most frequently diagnosed cancer of all cancers (Ferlay
J, 2013). The incidence and mortality of lung cancer in males is highest at 16.7% and 23.6%
respectively (Ferlay J, 2013), which is comparable to the 2008 global statistics suggesting that
lung cancer has been the major cause of cancer related deaths in males (Jemal et al., 2011). In
females over the last past 5 years, the incidence of lung cancer (8.8%) ranks 3rd behind breast
(25.2%) and colorectal (9.2%) cancer, but mortality rate ranks second (13.8%) behind breast
cancer (14.7%) (Ferlay J, 2013; Jemal et al., 2011). Overall, these data suggest the high
occurrence of lung cancer and the need for focused research to understand its complexity and to
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reduce the incidence and mortality of lung cancer. Lung cancer is predominantly caused as a
result of exposure to tobacco, with global estimates indicating that about 80% of men and 50%
of women affected by lung cancer as a result of smoking (Ezzati et al., 2005; Ezzati and Lopez,
2003). In non-smokers, cause of lung cancer is attributed to their genetic susceptibility
(Govindan et al., 2012) and environmental or occupational exposure to chemicals (asbestos,
burning coal (Subramanian and Govindan, 2007), arsenic, polycyclic aromatic hydrocarbons) or
radiations (ultra-violet light, radon) (Gorlova et al., 2006; Jemal et al., 2011; Parkin et al., 2005).
As a result of the exposure to carcinogenic agents in smokers and non-smokers, malignant
transformation of normal cells takes place. This involves genetic damage and oncogenic
signaling that eventually leads to dysregulation of normal cellular functions. Lung cancer is
broadly classified based on their cell size as small-cell lung carcinoma (SCLC) and non-small
cell lung carcinoma (NSCLC). More than 85% of lung carcinoma constitutes NSCLC that are
further classified based on specific histologic typing (Travis et al., 2013). 70% of SCLC and 50%
of NSCLC show mutations in p53 (Lane, 1992; Takahashi et al., 1989). Tumor suppressor gene
p53 located on chromosome 17p13 is considered as guardian of a cell genome that functions in
repairing DNA damage in G1 phase of cell cycle, before allowing cells to progress to S-phase of
cell division. In an event of failure to repair the DNA damage, p53 activates apoptosis pathway
that eventually results in cell death. Research studies have indicated that p53 mutations are most
frequent in tobacco smokers thereby suggesting p53 as a mutational hot-spot.

The lung is a complex organ with a wide variety of cells with identification of stem/ progenitor
cells with specific cell surface markers enabling researchers to characterize lung cells with
multipotent stem cell characteristics. However, specific roles and characteristics of resident
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stem/progenitor cells expressing Gain of Function (GOF) mutations are still unknown. In the
present study, we present evidence for the first time the ability to isolate and establish
stem/progenitor cells from mice lung cancer models carrying p53-GOF mutations. The single
knock-in GOF p53R172H/+ mutation in this study is arginine substituted histidine in the DNA
binding region of the p53 protein. The triple knock-in p53QSH/+ has substitutions in
transactivation domain (L25Q, W26S) (Johnson et al., 2005) and DNA binding domain (R172H)
(Olive et al., 2004; Vaughan et al., 2013). Both of these GOF mutations lead to expression of
mutant p53 protein which results in selective disrupted biological functions. We hypothesize that
multipotent lung stem cells (MLSCs) isolated from mice carrying p53-GOF mutations exhibit
limited differentiation potential and higher self-renewal capabilities. Here, we report for the first
time, morphological, phenotypical, and functional differences of MLSCs established from mice
lungs across the different p53 backgrounds.

2.3
2.3.1

Materials and methods
Lung isolation, enzymatic digestion, and cell sorting

The lungs were dissected from p53+/+ Wild type C57BL/6 and conditional mutants p53R172H/+
(Olive et al., 2004) and p53QSH/+ following the steps described (Gadepalli et al., 2013; Hegab et
al., 2010). For the purpose of this study, lungs from two mice (n=2) were harvested from
respective p53 backgrounds. Briefly, the mice were anesthetized by intra-peritoneal (IP) route
and sacrificed by cervical dislocation. Careful dissection is performed from posterior to anterior
end of the abdomen to locate trachea near throat region. 1 ml of dispase (2U/ml) is injected after
a slight incision made on trachea. Following the injection of dispase, the inflated lungs were
carefully harvested along with trachea and other visceral organs. The lung lobes were separated
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from the other body parts and incubated in sterile solution containing dispase and collagenase to
obtain slurry of the lung tissue (Gadepalli et al., 2013). Finally, the red blood cells (RBC) and
undigested lung tissue were separated by addition of RBC lysis buffer, rinsing in sterile PBS++
(with Mg2+ and Ca2+) and filtering through 0.45 µm sterile filter. The cells are counted and plated
at 1000 cells per cm2 and expanded for 21 days.

Figure 2-1: Schematic representation of lung isolation, digestion, and sorting.
(i) Separation of lung lobes, mincing lung tissue, and enzymatic digestion to prepare single cell
suspension. (ii) RBC lysis and filtration of undigested lung tissue. (iii) Rinsing in growth
medium, cell counting and plating in appropriate tissue culture-treated flask. (iv) Collection of
single cells in trypsin, neutralize with growth medium and PBS++ wash. (v) Fluorescent
conjugated Antibody staining with appropriate controls, depletion of PE positive cells and FACS
sorting of lung subpopulations differentially expressing Sca-1 (vi) Propagating cells in growth
medium for downstream cell analysis.
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2.3.2

Cell culture components

As the current study aims to establish and characterize primary cells with stem cell
characteristics following similar marker combination reported by (Hegab et al., 2010), we opted
to use the same medium composition that was shown to be conducive for propagating these cells.
The components for growth medium are 10% defined FBS (HyClone Laboratories, Logan, Utah
USA), DMEM-High glucose with Glutamine & sodium pyruvate 1x Penicillin/Streptomycin, 1x
NEAA. Splitting of cells was carried at near confluence with 0.25% trypsin. Cryopreserved cell
stocks were prepared at regular passages using freezing medium containing 10% DMSO and
30% defined FBS. All reagents were obtained from Life Technologies (Grand Island, NY, USA)
unless otherwise noted.

2.3.3

FACS sorting and analysis of cell surface marker expression

The goal of the study is to establish lung stem/progenitor cell lines from mice with different p53
genetic background, based on expression of cell surface marker Sca-1. For this purpose, the cells
were passaged using 0.25% trypsin, washed with PBS++ and suspended in 100 µl volume of
PBS++ with respective concentration of conjugated antibody for staining, as described in (
Appendix i). The cells were incubated on ice for 30 minutes and washed twice with PBS++.
Sorting of the stained cells is performed on BSC Aria- BD FACSAria™ II High-Speed Cell
Sorter (BD Biosciences, Franklin Lakes, NJ, USA) at flow cytometry shared resource, VCU. For
the current study, the cells were sorted based on the following expression of cell surface marker,
Sca-1High, CD31neg, CD45neg and Sca-1Low, CD31neg, CD45neg. All the sorting procedures were
conducted under sterile conditions and respective fluorophore isotype IgG control were
employed as negative control.
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For analysis of differential expression of Sca-1 marker across the different p53 background mice,
unsorted cells were plated in 100 cm dish (in replicates). At near confluence, the uniform
staining protocol was employed as described in (
Appendix i). The expression differences were evaluated on BD Accuri™ C6 flow cytometry. For
this purpose, equal numbers of flow events were collected across all the samples in this study in
replicates. Analysis was carried out using respective fluorophore isotype controls. Statistical
differences were assessed using Students t-test and p-value <0.05 was considered significant.

2.3.4

Immunocytochemical analysis for Sca-1 expression

Sorted Sca-1High and Sca-1Low cells across all the p53 backgrounds were seeded on 0.1% gelatin
coated glass bottom 35 mm dishes (MatTek Corporation, Ashland, MA, USA) at 2000 cells per
well. After 24 hours or at 80% confluence, the cells were fixed with 4% PFA and stained with
mouse Sca-1/Ly-6 primary antibody and Goat Anti-Rat IgG NL557, secondary antibody (R&D
Systems, Minneapolis, MN, USA). The nuclei were stained with DAPI (EMD Millipore,
Billerica, Massachusetts USA). Briefly, 10 µg/ml of primary antibody in a 300 µl of blocking
buffer (3% goat serum in PBS+/+) was added to the cells and the plates were incubated overnight
at 4oC. The sample were prepared for imaging by 1 hour incubation with secondary antibody,
followed by PBS+/+ washes and nuclear stain with DAPI. Fluorescent images were acquired
using a CoolSnap EZ camera 29 (Photometrics, Tucson, AZ, USA) mounted on a Nikon Eclipse
TE 2000-S inverted microscope (Nikon, Melville, NY, USA) with attached image analysis
software. All images settings were controlled for uniform acquisition between the samples.
Specifically, uniform exposure time of 500ms was maintained across the experimental samples
and as well as the negative controls for background subtraction.
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2.3.5

AlamarBlue® cell proliferation assay

The differences in propagation for Sca-1 sorted cells were determined by AlamarBlue® Cell
viability (Life Technologies, Grand Island, NY, USA). In this study, to determine cell growth
over a period of 7 days, the Sca-1High and Sca-1Low subpopulations across the wild type and
mutants were trypsin passaged at confluence and cell counts were determined on BD Accuri™
C6 (BD Biosciences, Franklin Lakes, NJ, USA), as described in
Appendix ii). 500 cells were plated per well in a 96-well plate in quadruplicates for respective
lung cell lines. After allowing the cells to attach to the tissue culture plate for 4 hours the
medium is aspirated and a fresh growth medium mixed with 10% AlamarBlue® reagent was
added. Absorbance was measured at a wavelength of 570 nm and 600 nm using Synergy H1
plate reader. Continuous readings were obtained every day for a period of 7 days without
changing the growth medium. Wells with growth medium alone and growth medium plus 10%
AlamarBlue® reagent were run as blanks. The experiment was repeated at two different passages
and OD readings were averaged across the experiments. The percent reduction of AlamarBlue®
reagent is calculated by the following equation,
AR570=�A570-(A600×Ro)�×100
Where,
AR570 = Amount of reduced AlamarBlue® reagent
A570 & A600 are sample absorbance at respective wavelength minus media blank
Ro = Correction factor. This is calculated by AO 570 ÷ AO 600, where AO 570 and AO 600 are
the Absorbance of Oxidized (AO) form of AlamarBlue® reagent, at respective wavelengths. AO
= OD 10% AlamarBlue® in medium - OD growth medium, at respective wavelengths.
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2.3.6

Cell cycle profile analysis

To evaluate the percentage of actively dividing cells in Sca-1High and Sca-1Low lines established
across the different p53 backgrounds, the cells were stained with propidium iodide. Briefly, at
near confluence, cells were subjected to Trypsin treatment and cell counts were determined as
described in
Appendix ii). For use in cell cycle analysis, 5×104 cells were plated per 10 cm2 (35 mm) tissue
culture plates. The cells were allowed to propagate for 24 -48 hours, allowed to reach 80%
confluency, collected together after Trypsin treatment, washed with PBS++, fixed in cold 70%
ethanol and stored at -20oC until analysis. Further, DNA is stained with 20 µg/ ml of propidium
iodide (St. Louis, MO, USA). Equal number of events are collected across all the samples using
BD Accuri™ C6 flow cytometry and analysis is carried using FCS Express 4. The detailed
procedure for staining is described in Appendix. Samples were analyzed in triplicates and
statistical significance was determined by student t-test, with p-value <0.05 considered to be
significant.

2.3.7

In-vitro scratch assay for analysis of cell migration

The tumorigenic potential of p53 mutant backgrounds with respect to the normal wild type cell
lines was determined by quantifying migration ability of cells. For this purpose sterile silicone
culture inserts (ibidi LLC, Verona, WI, USA) were used, designed to create cell free gap of 500
µm. The respective wild type and mutant cell lines were passaged with trypsin, quenched in
growth medium and cell counts determined as described in
Appendix ii). The inserts were placed in a 12-well dish with sterile forceps. Lines were drawn on
the external bottom surface of each well of the 12-well dish with a marker pen for proper
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orientation during imaging. Approximately, 500 cells were plated in the culture inserts and
placed in the incubator for 24 hours. The inserts were carefully removed with sterile forceps,
plates rinsed in with PBS++ and fresh medium was added. At 1st time point (0 hours), images of
the cell free gap created after removing the culture inserts was captured in proper orientation
based on the markings created underneath the well surface. The plates were returned back to the
incubator and images captured after 6 hours in the same orientation and at the same position
corresponding to the earlier time point. The experiment was conducted in duplicates with 3
points of measurement for each well. The images were captured with CoolSnap EZ camera
(Photometric, Tucson, AZ, USA) mounted on Nikon Eclipse TE2000-S inverted microscope
(Nikon, Melville, NY, USA). The distance of the cell free gap was measured with Nikon NIS
Elements-Br imaging software between two time points. A total of nine measurements were
acquired for each cell line and statistical significance was determined by student t-test. The
migration rate (µm/hr.) was calculated using the following formula.

µm Starting distance (µm) - Final distance(µm)
�=
hr
Time (hours)

Migration rate �
2.3.8

Soft agar non-adherent cell culture assay

The tumorigenic potential of the p53 mutant cell lines was determined by their ability to form
spheres in anchorage independent culture conditions. For this purpose, 1% pure agarose
(BioExpress, Kaysville, UT, USA) was autoclaved and appropriate amount (2ml) was poured
into 6-well tissue culture plate to prevent cell attachment. The cells were passaged as described
in
36
Back To Table of Contents

Appendix ii and 10,000 cells were plated per well of 6-well plate. After addition of the growth
medium, the cells were returned to the CO2 incubator and cell growth monitored for a period of
10-14 days. 1 ml of fresh growth medium was added without replacing the old medium every 2
days. The experiment was conducted in duplicates at two different passages. All cell colonies in
suspension that grew in size were counted across triplicates. Statistical significance was
determined by student t-test, with p-value<0.05 considered to be significant.

2.3.9

Mesenchymal lineage differentiation analysis

The multipotent differentiation capability of the Sca-1High and Sca-1Low lines established across
the different p53 backgrounds was evaluated by their ability to differentiate into osteogenic and
adipogenic lineage. For osteogenic differentiation, 10,000 cells were plated per well of a 12-well
tissue culture plate in growth medium. At 70 % confluence, the growth medium is replaced with
osteogenic differentiation medium containing 10nM Dexamethasone, 50 µM L-Ascorbic acid 2phosphate and 20mM ß-Glycerophosphate disodium salt hydrate. The cells were propagated for
a period of 14-21 days. At the end of the differentiation period, the cells were fixed with 4%
Paraformaldehyde. The deposition of calcium was detected with 40 mM Alizarin red stain. For
adipogenic differentiation, 20,000 cells were plated per well of a 12-well tissue culture plate in
adipogenic differentiation medium containing 1:50,000 dilution of 1mM insulin and 1:10,000
dilution of 10 µM T3. At 100 % confluence, the differentiation medium is replaced with
adipogenic induction medium containing 0.125M Indomethacin, 2mg/ml dexamethasone, 0.25M
IBMX along with 1mM insulin and 10 µM T3. The cells were induced in the induction medium
for 2 days and later maintained in adipogenic differentiation medium for 5 more days. At the end
of differentiation, the cells were fixed in 10% formaldehyde. The formation of lipid droplets was
37
Back To Table of Contents

detected with Oil Red O staining solution. Further details of the differentiation protocol and
staining procedure are described in Appendix iii. All reagents were obtained from Sigma (St.
Louis, MO, USA) unless otherwise noted.

2.3.10 RNA isolation, real time reverse transcription polymerase chain reaction, and gene
expression analysis.

To quantitate expression of genes of interest listed in Appendix iv, cell pellets were collected and
RNA purification was performed using AllPrep DNA/RNA Mini Kit following manufacturer
instructions (Qiagen, Valencia, CA, USA). The RNA concentration of the samples was
determined by Nanodrop 2000c spectrophotometer (Thermo scientific, Wilmington, DE, USA)
and 1µg of RNA across all the sorted cell lines was converted into cDNA using High-Capacity
cDNA Reverse Transcription Kit (Life Technologies, Grand Island, NY, USA ). Q-PCR reaction
was setup using iTaq Universal SYBR Green supermix (BioRad, Hercules, CA, USA) with
appropriate concentration of primer and cDNA. The primer efficiencies of the internal control
(GAPDH) and genes of interest were determined by a standard curve. Gene expression data (in
triplicates) were acquired using CFX 96 real time system (C1000 touch). Details of the q-PCR
setup and protocol are described in
Appendix v). GAPDH was run as a housekeeping reference gene and analysis was performed by
normalizing the expression quantity of gene of interest to the expression quantity of internal
control gene using the relative standard curve method (Livak and Schmittgen, 2001; Schmittgen
and Livak, 2008). Statistical significance was determined by student t-test, with p-value <0.05
being considered as significantly different.
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2.3.11 Western blot analysis
To determine the expression of p53 protein in the sorted Sca-1High and Sca-1Low lines established
across the different p53 backgrounds, cells were plated at 5000 cells per cm2 in respective 60
mm (area 20 cm2) tissue culture plate and propagated to 90% confluence. Cells were collected in
trypsin, quenched, washed with PBS++, and cell pellets placed on ice. Protein extraction was
performed using RIPA lysis buffer following the supplier protocol. Protein concentrations were
determined using Bradford assay. The crude protein lysate obtained across the different cell lines
were probed for expression of p53 and ERK-2 by Western blot using specific antibodies (Santa
Cruz Biotech, Dallas, Texas, USA). Anti-rabbit HRP-conjugated antibody was used as secondary
antibody (CST, Danvers, MA, USA). Detection was carried out by developing the membrane in
with ECL substrate solution (Thermo scientific, Wilmington, DE, USA) and images were
captured using Gel Doc™ XR+ system (BioRad, Hercules, CA, USA).

2.3.12 Genotyping assay by PCR
DNA isolation and purification was performed using AllPrep DNA/RNA Mini Kit following
manufacturer instructions (Qiagen, Valencia, CA, USA). Standard PCR reaction was setup with
appropriate concentration of 3 primers, DNA and reagents. The genotyping strategy is to span
the LoxP site in the mutant and to distinguish them from wild type. The PCR products were run
on a 2% agarose gel to determine genotype of the wild type or mutant cell lines based on
presence or absence of LoxP. Detailed description of the protocol can be found in
Appendix v).
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2.3.13 Colony formation assay
To determine the colony forming ability of sorted cells, cells were plated at low density 5 cells
per cm2 on inactivated mouse embryonic fibroblasts (iMEFs) and allowed to propagate for 7
days. The cells were collected in trypsin, quenched in growth medium and cell counts
determined as described in
Appendix ii). Later, they were fixed in 10% ice cold methanol and colonies were stained with
1% crystal violet solution (Sigma, St. Louis, MO, USA).

2.4
2.4.1

Results
Sca-1 expressing putative lung stem cells across p53 backgrounds

Taking into consideration the complex nature of the lung and based on previous studies(Hegab et
al., 2010; Kim et al., 2005; McQualter et al., 2009), we expect that Sca-1pos, [hematopoietic
(CD45neg) and endothelial (CD31neg)] linneg cell population comprises more than one type of
putative lung stem/progenitor cells. Additionally, with increasing evidence of two different
subpopulations within the Sca-1pos cells, it is important to compare and characterize them for a
better understanding of lung biology. Towards use in this comparative study, single cell
suspensions were obtained by enzymatic digestion of lungs (n=2) dissected from mice from
different p53 genetic backgrounds. Since the population of linneg and Sca-1pos cells in lungs were
determined to be a rare subpopulation, we plated the unsorted single cells into an appropriate
tissue culture (TC) flask (T75) and propagated them with regular growth medium changes. In
order to minimize cell culture induced changes in in vitro conditions, we avoided splitting and
expanding the population before sorting. We noted that the unsorted lung cells obtained from the
mutant p53 background mice reached confluence in about 15-20 days while the p53+/+ wild type
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cells took more than 20 days to reach confluence. After enriching the unsorted lung cells, single
cell suspensions were stained with fluorescent conjugated somatic stem cell marker Sca-1-FITC,
and lineage markers for hematopoietic (CD45-PE) and endothelial (CD31-PE) cell surface
markers. Linpos cells were depleted and Sca-1Low and Sca-1High subpopulations were collected
using BD FACS Aria™ II high-speed cell sorter. Our results indicate that even though Sca-1High
and Sca-1Low subpopulations are not distinctly concentrated in a particular region of the Forwardscatter (FS)-area vs Side-scatter (SS)-area or on the fluorescence (FITC) dot plot, they could be
gated as high and low expressing populations based on their spread. We noticed that the
percentage of cells staining positive for CD45 and CD31 were lower in cell suspension obtained
from in vitro culture than those obtained directly from lung tissue. We speculate that these linpos
cells were loosely adhered or have limited propagation ability and were lost during growth
medium changes. Upon sorting, the Sca-1Low and Sca-1High cell subpopulations from different
p53 backgrounds were propagated in TC plates (35mm) with growth medium. We further
performed immunofluorescence staining to validate our sorting strategy, as shown in (Figure
2-3). Under uniform exposure conditions, we noted the Sca-1High populations stained positive,
while the Sca-1Low populations were predominantly negative with few positive cells.
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Figure 2-2: FACS sorting of Sca-1 expressing lung stem cells across p53 backgrounds
FACS sorting is performed with appropriate gating to deplete linpos cells (CD45 and CD31) from
single cell suspension prepared from the whole lung harvested across the respective p53
backgrounds. The remaining lung cell subpopulations were sorted for Sca-1High and Sca-1Low and
plated in tissue culture dish for propagation.

42
Back To Table of Contents

Figure 2-3: Differential Sca-1 expression in Sca-1 High and Sca-1 Low sorted cell lines
Immunocytochemical analysis for Sca-1 shows differential staining patterns across the mutant
and the wild type lines. The Sca-1/Ly-6 expression is show in red and nuclei were stained with
DAPI (blue). Scale bar represents 50µm.
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2.4.2

Sca-1 expressing lung stem cells from p53 mutants possess higher proliferation and
self-renewal characteristics

Our phenotypic assays on proliferation and self-renewal ability on the sorted Sca-1
subpopulations have demonstrated differences between the wild type p53 and mutant p53 cell
lines. Comparing morphology under inverted microscope (Nikon TS100), we did not observe
differences in cell morphology within the Sca-1Low and Sca-1High subpopulations established
across the respective p53 backgrounds. However, we noted distinct morphological differences
between the p53+/+ wild and p53 mutant cell lines. The p53 wild type cell lines were more
heterogeneous, with small spindle shaped cells and cobblestone appearances, while the mutant
cell lines were predominantly homogenous with elongated mesenchymal cell morphology
(Figure 2-4). This observation is supported by our quantitative-PCR studies, where significantly
higher mRNA transcript levels of N-cadherin was observed in p53 mutant cells relative to the
wild type. Additionally, between the Sca-1Low and Sca-1High of the mutant cell lines, Sca-1High
subpopulations possess higher levels of N-cadherin, supporting the mesenchymal nature of the
putative cancer stem cells (Figure 2-5). We also observed that lung subpopulations derived from
p53 mutant background were more easily detached from the cell culture plate compared to the
wild type subpopulation, an indicative of their mesenchymal nature. Our proliferation curves
were determined by ability of viable cells to reduce resazurin, an active ingredient in
AlamarBlue® reagent, into fluorescent resorufin. As indicated by proliferation curves (Figure
2-6), the subpopulations derived from p53 mutant backgrounds possess higher proliferation
compared to those derived from p53 wild type. This is also supported by our cell cycle analysis,
where higher percentage cells carrying p53 mutants were analyzed to be in the S and G2/M
phase of the cell cycle (Figure 2-7).
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Furthermore, we investigated the self-renewal ability of the Sca-1 subpopulations to form
colonies at low seeding density over a period of 7 days. Our results show that Sca-1
subpopulations expressing wild type p53+/+ cells fail to form large colonies at low seeding
density during this time, while the same subpopulations from p53 mutant mice formed distinct
large colonies (Figure 2-8). In order to further ascertain the self-renewal characteristic of the
lung subpopulations from different backgrounds, we quantified the expression levels of BMI-1.
BMI1 expression plays a crucial role in self-renewal of stem cells and as well as in cancer
progression (Siddique and Saleem, 2012). Specifically, in lungs, BMI-1 deficient
bronchioalveolar stem cells lack self-renewal property (Dovey et al., 2008; Zacharek et al.,
2011). Moreover, BMI-1 is elevated across diverse tumor types, thus suggesting that BMI-1
plays a key role in regulating proliferation of both stem cells and tumor cells (Dovey et al., 2008;
Siddique and Saleem, 2012). Our results show that Sca-1 lung subpopulations carrying p53
mutations possess significantly higher BMI-1 levels relative to those derived from p53+/+ wild
type mice (Figure 2-9). We also observed significant increase in expression levels of BMI-1
across different human lung cancer lines relative to normal human bronchiolar endothelial cells
(Figure 2-9). Overall, our results demonstrate that Sca-1 expressing subpopulations from the p53
mutant mice are an actively dividing and self-renewing population compared to those derived
from p53+/+ wild type mice.
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Figure 2-4: Lung stem cells from p53 mutant mice show distinct mesenchymal morphology.
Distinct morphological differences are observed between p53+/+ wild type and the mutant cell
lines. The p53+/+ wild type cells possess small spindle shape morphology and the cell lines from
mutant backgrounds possess longer mesenchymal morphology. Scale bar 20x magnification.
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Figure 2-5: Sca-1 expressing lung cells from mutant p53R172H/+ mice show higher Ncadherin expression
Relative transcript levels of N-cadherin across the p53 backgrounds and between the sorted cell
lines (A) Sca-1 High (B) Sca-1 Low, were determined by Q-PCR and fold change was calculated
by relative standard curve method with p53+/+ wild type as reference cell line. Results are
presented together with standard deviation from experiment conducted in triplicates. (* = p <
0.05).
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Figure 2-6: Sca-1 expressing lung cells from p53 mutants show higher proliferation
Proliferation curve of the established cell lines was determined over a period of 7 days in
medium containing Alamar blue reagent. The percent reduction in Alamar blue reagent was
measured by absorbance at 570 nm with 600 nm as reference. The active growth of the cells is
proportional to the amount of Alamar blue reagent reduced. The lung sub-population established
from p53 mutant background attained confluence at day 4 while, the p53 wild type cells reach
confluence at day 6 Results are presented together with standard deviation from two independent
experiments conducted in quadruplicates. (* = p <0.05).
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Figure 2-7: Sca-1 expressing lung cells from p53 mutant mice show lower percentage of
cells in G-1 phase and higher percentage in S and G2/M phase of cell cycle.
The higher proliferation potential of the p53 mutant cell lines were analyzed by determining the
cell cycle phases using propidium iodide (PI) staining and analyzed with Accuri C6 flow
cytometry. Error bar represents standard deviation across experiments conducted in triplicates (*
= p <0.05).
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Figure 2-8: Sca-1 expressing lung cells from p53 mutant mice show colony formation
ability at low seeding density
The ability of Sca-1 subpopulations sorted across the p53 mutants to form colonies was
evaluated by plating cells at low seeding density on inactivated mouse embryonic fibroblasts
(iMEF). The colonies were stained with crystal violet stain after a period of 6 days. Data from
experiment performed in triplicates was used for analysis.
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Figure 2-9: Sca-1 expressing lung cells from mutant p53 show higher levels of BMI-1
mRNA expression
Relative transcript levels of BMI-1 across the p53 backgrounds were determined by Q-PCR and
fold change was calculated by relative standard curve method with p53+/+ wild type as reference
cell line. Results are presented together with standard deviation from experiment conducted in
triplicates. (* = p < 0.05).
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Figure 2-10: Higher expression of BMI-1 is observed in human lung cancer lines
Gene expression levels of BMI-1 across the human cancer cell lines were determined by Q-PCR
and fold change was determined by comparative Cq method with normal human bronchiolar
endothelial (NHBE) cells as reference cell line. Results are presented together with standard
deviation from experiment conducted in triplicates. (* = p < 0.05).
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2.4.3

Conditional point mutant p53 are expressed in lung subpopulations that are sorted
based on cell surface marker Sca-1

The GOF mutations p53R172H/+ and p53QSH/+ investigated in this study are conditional
heterozygous mutant alleles, expressing point mutations in p53 protein, and activated by Cremediated recombination as described in an earlier study (Olive et al., 2004). In our study, we
determined the genotype of these mutants and wild type by standard PCR with a 3 primer
combination based on published protocols (Olive et al., 2004). Our results indicate the
expression of these conditional mutants in Sca-1Low and Sca-1High sorted lung cells are as
anticipated. Results show the PCR amplification with a 3 primer combination resulted in only a
control product of 166 bp in p53 wild type cells, while the p53 mutant background cells express
both the control product of 166 bp and 270 bp LOXP LSL element (Figure 2-11). We further
determined the ability of the conditional mutants to express aberrant p53 protein that results in
accumulation of p53 protein. As expected, Western blot analysis show that p53+/+ wild type cell
lines did not have any p53 protein accumulation for both Sca-1High and Sca-1Low subpopulations
(Figure 2-12). The subpopulations from the p53 mutant cell lines, p53R172H/+ and p53QSH/+, shows
p53 protein accumulation, suggesting that alleles with point mutations in p53 are expressed in
the engineered knock-in mice models.
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Figure 2-11: Genotyping by PCR amplification of conditional mutant alleles results in a
270 bp mutant product and a 166 bp control product.
(A) PCR products run on 1% agarose gel (1) Wild type, (2) p53R172H/+, and (3) p53QSH/+ cell lines
expressing (a) Sca-1High and (b) Sca-1Low. (L-100 bp ladder). (B) Primer combinations that yields
the respective PCR product wild type allele (166 bp) detected by T037, T035, and (270bp)
detected by T036, T035 flanking the LSL element.
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Figure 2-12: Sca-1 expressing lung cells from p53 mutant cell lines show accumulation of
p53 protein.
Whole cell lysates were extracted from Sca-1 expressing lung subpopulations across the p53
backgrounds and were analyzed for expression of p53 and ERK-2 (housekeeping control). The
conditional point mutants p53R172H/+ and p53QSH/+ show accumulation of p53 protein while the
p53+/+ wild type show no p53 accumulation.
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2.4.4

Cell lines from p53 mutant mice possess higher percentage of Sca-1 expressing cell
populations

We compared the percentage of cell populations expressing Sca-1High and Sca-1Low across
different p53 backgrounds using flow cytometry analysis. For these comparisons, we performed
independent flow cytometry analysis on unsorted lung cells propagated in TC plates (100 mm).
We noted that there is a significant difference in the number of Sca-1High cells across the mice
with different p53 genotype backgrounds. Our results indicate that approximately 75% of
unsorted lung cells from p53R172H/+ and 74% of p53QSH/+ can be classified as Sca-1High population,
while only 61% of p53+/+ wild types are Sca-1High (Figure 2-13). Similarly, we noted that
percentage of Sca-1Low is significantly lower in p53 mutant cell lines, but higher (33%) in p53+/+
wild types. This observation was also supported by our q-PCR analysis, where Sca-1 mRNA
transcript levels are significantly higher in the Sca-1High population in p53 mutant cell lines
relative to the p53+/+ wild types (Figure 2-14).
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Figure 2-13: Cell lines isolated from p53 mutant mice lung possess higher percentage of
Sca-1 expressing cells
Unsorted lung cells established across different p53 background were propagated in culture and
cells differentially expressing Sca-1 were analyzed by flow cytometry. (A) Scatter plots of
unsorted cells stained with Sca-1-FITC (y-axis) and CD45-PE, CD 31-PE (x-axis) (B) Bar plots
show significant differences in percentage of cells expressing Sca-1, PDGFR-α between the p53
backgrounds. (* = p < 0.05). Results were presented together with standard deviation from 3
independent experiments.
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Figure 2-14: Sca-1 expressing lung subpopulations from p53 mutant cell lines show higher
transcript levels of Sca-1
Q-PCR analysis of respective transcript levels of Sca-1 mRNA across the p53 backgrounds. Sca1 expressing lung subpopulations from p53 mutants show significantly higher mRNA levels of
Sca-1 compared to the p53+/+ wild type. Results are presented together with standard deviation
from experiment conducted in triplicates. (* = p < 0.05).
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2.4.5

Sca-1 expressing lung cells from wild type p53+/+ cells show higher differentiation
ability

We determined the multipotent differentiation capability of the sorted cells across different p53
backgrounds by subjecting them to conditions that lead to formation of adipocytes and
osteocytes, considered to be traditional mesenchymal lineages. Our results show that the p53+/+
Sca-1High subpopulations readily differentiated compared to the Sca-1Low subpopulations. Our
results indicate that the p53+/+ Sca-1High subpopulations show distinct Oil red O staining patterns,
indicative of adipogenic differentiation, after a period of 10 days (Figure 2-15), while the Sca1Low subpopulation exhibited fewer oil droplet formation indicative of limited differentiation
potential. Similar differentiation potential was noted when p53+/+ wild type cells were subjected
to osteocyte differentiation conditions for a period of 14-21 days, with robust calcium deposition
in p53+/+ Sca-1High cells than in Sca-1Low cells (Figure 2-16). However, we observed that p53
mutant cell lines p53R172H/+ and p53QSH/+ did not exhibit adipogenic differentiation potential, with
differentiation conditions resulting in loss of cell viability during multiple attempts (Figure
2-15). Under osteogenic differentiation conditions, the Sca-1Low subpopulations from the p53
mutant cell lines exhibited distinct calcium deposition, while the Sca-1High subpopulations from
these p53 mutant backgrounds showed some heterogeneous calcium deposition (Figure 2-16),
indicating that the p53 mutant cell lines have propensity for osteogenic differentiation.
Interestingly, the subpopulations from the p53 mutant mice expressed tissue specific alkaline
phosphatase, indicative of propensity for osteogenic differentiation (Appendix vi).
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Figure 2-15: Sca-1High lung subpopulations from p53+/+ wild type mice show distinct
adipogenic differentiation ability
The sorted cell lines across the different p53 backgrounds are propagated in adipogenic
differentiation medium for 10 days. Formation of lipid vacuoles that stain with oil red o stain at
the end of differentiation period is indicative of adipogenesis. The Sca-1High wild type
subpopulations show distinct Oil red O droplet formation compared to the Sca-1Low lung
subpopulations. Sca-1 expressing lung cells from p53 mutant mice exhibited loss of viability
indicating detrimental effects of the adipogenic differentiation medium.
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Figure 2-16: Sca-1High lung subpopulations from p53+/+ wild type mice show distinct
osteogenic differentiation ability
The sorted cell lines across the different p53 backgrounds are propagated in osteogenic
differentiation medium for 21 days. Deposition of calcium that stain with Alizarin red S at the
end of the differentiation period is indicative of osteogenesis. The Sca-1High and Sca-1Low
subpopulation from p53+/+ wild type and Sca-1Low subpopulation from p53 mutant cell lines
show distinct Alizarin red S staining.
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2.4.6

Sca-1 expressing lung subpopulations from p53 mutant mice show selective
tumorigenic effects

The tumorigenic property of the cell lines derived from cancer- sensitized p53 mutant (p53R172H/+
and p53QSH/+) mice, were determined by anchorage independent growth and migration assay. Our
results clearly indicate that subpopulations derived from p53+/+ wild type mice exhibit no colony
forming ability in anchorage independent growth on soft agar over a period of 10 days, while the
subpopulations derived from the p53 mutant mice demonstrated ability to form colonies and
grow in size in anchorage independent growth conditions during the same time period.
Specifically, Sca-1High subpopulations derived from p53 mutant mice demonstrate higher colony
formation compared to the Sca-1Low, subpopulations (

Figure 2-17). To determine the migration rate, we captured images of cells in defined regions at
0 and 6 hrs after initiation of the assay as described in the methods section (Appendix vii). Our
observations indicate that the subpopulations from the p53+/+ wild type and p53QSH/+ mice
possess a similar migration rate, while the subpopulation from the p53R172H/+ mice exhibited a
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significantly higher migration rate (Figure 2-18); Overall, our results at the in vitro level indicate
that subpopulations derived from the cancer sensitized p53 mutant mice exhibited tumorigenic
properties. However, our observations indicating differences existing between subpopulations
derived from different cancer-sensitized p53 mutant mice is noteworthy and alludes to potential
differences in tumorigenic properties based on specific p53 mutant genetic backgrounds.
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Figure 2-17: Sca-1 expressing lung cells from p53 mutant mice show anchorage
independent growth
Colonies formed by lung sub-populations across different p53 backgrounds and histogram
representing the total number of colonies counted after 14 days in culture. (A) Sca-1 High (B) Sca1 Low. Data represented across two independent experiments conducted in replicates. (* = p <

0.05, ** = p < 0.01).
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Figure 2-18: Sca-1 expressing lung cells from p53R172H/+ mutant mice show higher
migration rate
Sca-1 expressing subpopulations across different p53 backgrounds were cultured to confluence
in wells of silicone culture inserts with defined cell free gap of 500 µm. The monolayer is
denuded by carefully lifting the inserts and distance between the denuded areas was measured at
0 and 6 hrs. Migration is shown pictorially at 20x magnification (A) and migration rate
graphically (B). Data represented across experiments conducted in triplicates and error bars
represent standard deviation. (* = p < 0.05).
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2.5

Discussion

Treatment of cancer requires elimination of all tumor cells that are capable of regenerating
tumors. A better understanding of tumor-recapitulating cells that are considered to be cancer
stem cells is essential for development of successful cancer therapies. Studies have shown that
characteristics of cancer stem cells vary with the genotype of the cancer (Curtis et al., 2010).
While some studies have shown the role of CD133 expressing lung cancer stem cells in tumor
regeneration (Chen et al., 2008; Eramo et al., 2008); there is also evidence for tumorrecapitulating ability of Sca-1 expressing lung cells (Curtis et al., 2010). Here we analyzed lung
cells differentially expressing Sca-1 across different p53 genotype backgrounds and
characterized the nature of these Sca-1 expressing cells in in vitro conditions. The heterozygous
mutant genotypes in this study, p53R172H/+ and p53QSH/+, were previously shown to possess tumor
spectrums different from p53+/- and p53Null mutants (Olive et al., 2004; Vaughan et al., 2012a).
The heterozygous and homozygous targeted point mutations in the p53 allele were reported to
possess high frequency of metastasis and distinct carcinoma development. In spite of an active
wild type p53 allele, these genotypes show tumor characteristics indicating a dominant negative
effect of the point mutation (de Vries et al., 2002). Since p53 point mutations result in expression
of mutant p53 protein, which prevents binding of p53 to DNA or MDM2 (de Vries et al., 2002;
Olive et al., 2004; Vaughan et al., 2012b), analysis of subpopulations derived from these
backgrounds in the context of lung cancer merits further attention.

Our study investigated the selective effects of these point mutations in Sca-1 expressing lung
cells which were shown to possess demonstrable self-renewal and differentiation characteristics
in normal lung stem cells (Hegab et al., 2010; Kim et al., 2005; McQualter et al., 2009). Our
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work indicates that the Sca-1High expressing lung cell subpopulation is significantly higher in p53
mutant mice when compared to the p53+/+ wild type mice, suggesting increased numbers of Sca1 expressing cells in cancer sensitized p53 mutant backgrounds. A similar observation of
increased number of Bronchioalveolar stem cells (BASC) in Lox-K-ras mice with atypical
adenomatous hyperplasias (AAH ) and adenomas was noted (Kim et al., 2005) and were found to
play a role in tumor initiation in vivo (Curtis et al., 2010; Kim et al., 2005). While we did not test
the tumor-initiating capabilities of the Sca-1High and Sca-1Low subpopulations derived from
cancer-sensitized p53 backgrounds in vivo, we have successfully demonstrated the tumorigenic
properties of these cells. Sca-1High cells across both the p53 mutant genotypes have demonstrated
higher proliferation, anchorage independent growth, and migration, indicative of their
tumorigenic properties. Our results also confirm p53 accumulation in the protein lysates obtained
from subpopulations derived from both mutant backgrounds, validating the expression of mutant
p53 protein. Even though our tumorigenic assays demonstrate the higher tumorigenic potential of
the subpopulations derived from the p53R172H/+ mice, these cell lines expressed low amount of
p53 protein compared to those derived from p53QSH/+ mutant mice. Our observations indicating
low levels of p53 accumulation in Sca-1 sorted cells from p53R172H/+ cell lines could be attributed
to the presence of an altered splice acceptor site in p53R172H/+, that results in reduced expression
of the mutant p53 protein (de Vries et al., 2002; Olive et al., 2004). B cell-specific Moloney
murine leukemia virus integration site 1 (BMI-1) protein has been shown to play a critical role in
self-renewal and differentiation of somatic stem cells in lung and other tissues (Siddique and
Saleem, 2012; Zacharek et al., 2011). Conclusions based on numerous studies indicate the role of
BMI-1 in progression, recurrence, and chemo-resistance of cancer cells. Our analysis of BMI-1
expression across cancer sensitized p53 mutants and p53+/+ wild type genotypes indicate that p53
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mutant cell lines express significantly higher BMI-1 mRNA levels. This higher mRNA levels
correlates to the observed tumorigenic properties, supporting the significance of BMI-1
expression in cancer sensitized p53 mutant cell lines.

Tissue specific adult stem cells exhibit self-renewal, a process by which stem cells divides to
make more stem cells, in order to maintain the stem cell pool throughout the lifespan. The role of
proto-oncogenes and tumor suppressor genes in controlling cell cycle, balancing self-renewal
and differentiation have been studied with results indicating that proto-oncogenes promote selfrenewal, while gate-keeper tumor suppressors limit self-renewal and care-taker tumor
suppressors maintain genomic integrity (He et al., 2009). The p53 gene exhibits both gatekeeper and care-taker functions (Jerry et al., 2008) and it is reasonable to expect that point
mutations result in disruption of both these functions. The Sca-1 expressing lung stem cells in
this study were sorted from mice carrying p53R172H/+, a model for Li-Fraumeni syndrome (Olive
et al., 2004), and p53QSH/+with compromised transactivation ability to induce apoptosis (Johnson
et al., 2005; Vaughan et al., 2013). We tested the stem cell properties of Sca-1 expressing lung
stem cells by assessing their multipotent differentiation ability into mesenchymal lineage. Sca1High and Sca-1Low subpopulations from p53+/+ wild type mice exhibited differentiation potential
into adipocytes and osteocytes, while those derived from p53 mutant mice exhibited limited
differentiation abilities. Our results also indicated that the adipocyte differentiation medium has
detrimental effects on the subpopulations derived from the cancer sensitized p53 mutant mice,
resulting in restricted growth and loss of cell viability. Our observations of loss of cells under
adipogenic differentiation conditions are similar to what has been observed by experiments
conducted on putative stem cells isolated from prostate cancer cells (Zhau et al., 2011). Based on
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our findings, we conclude that further studies need to be conducted to investigate the uni- and
multi- potent differentiation ability of these cells into specific lung lineages and other lineages.

In summary, our study highlights the existence of higher number of Sca-1 expressing putative
lung stem cells in cancer sensitized p53 mutant mice. Additionally, phenotypic and functional
studies support their tumorigenic properties and limited differentiation ability, suggesting that the
increase in Sca-1 population can be correlated to p53 mutations. Future in vivo studies are
needed to further confirm the stem cell nature, self-renewal and differentiation, as in vivo studies
captures the natural stem cell niche. The tumor initiating role of the Sca-1 expressing lung stem
cells needs further validation in vivo to investigate the importance of Sca-1 expressing cells from
p53 mutant backgrounds as cancer stem cells. Detailed characterization of these putative cancer
stem cells is expected to lead to the development of chemoprevention strategies for treating lung
cancer.
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CHAPTER 3: ISOLATION AND CHARACTERIZATION OF LUNG
STEM/PROGENITOR CELLS BASED ON SCA-1 & PDGFR-ΑLPHA

3.1

Abstract

The lung consists of different anatomically defined regions composed of large airways (bronchi),
bronchioles, and alveoli that harbor morphologically and functionally distinct mesodermal and
endodermal cell types. Within these complex structures, studies have shown the existence of
candidate cells that exhibit stem cell characteristics of self-renewal and differentiation.
Identification of Sca-1 expressing lung cells has been the most common approach in isolation of
these resident lung/ stem progenitor cells. To reduce cellular heterogeneity, studies have focused
on combination of different cell surface markers along with Sca-1 to identify and characterize
stem/progenitor cells with defined stem cell characteristics. Here we incorporated a two marker
strategy to identify and characterize lung cells differentially expressing Stem cell antigen-1 (Sca1) and Platelet derived growth factor-alpha (PDGFR-α). By employing fluorescence-activated
cell sorting (FACS), we have established multiple subpopulations of cells from the murine lung
and evaluated their phenotypic and functional properties. Our results suggest that except for Sca1LowPDGFR-αHigh subpopulations, all the subpopulations possess mesenchymal differentiation
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potential into adipocytes and osteocytes, suggesting that Sca-1LowPDGFR-αHigh subpopulation
lacks stem cell characteristics. We also noted that these subpopulation possess higher
proliferation, and high N-cadherin expression indicating their mesenchymal nature. On the
contrary, we observed robust differentiation ability in both Sca-1HighPDGFR-αHigh and Sca-1High
PDGFR-αLow subpopulations, but lower proliferation ability in the latter. Initial FACS analysis in
p53 mutant lines indicate the presence of a high percentage of Sca-1HighPDGFR-αHigh
subpopulation, which alludes to the importance of PDGFR-α as a potential cancer stem cell
marker. Overall, our results demonstrate the potential use of PDGFR- α in sorting for
subpopulations with defined stem cell characteristics and to further determining its importance in
the context of lung cancer.

3.2

Introduction

Understanding the role of somatic stem cells in different tissues to maintain homeostasis and
wound healing is still an area of active research. Numerous studies have uncovered existence of
different somatic cells, non- hematopoietic stem cells, with multipotent characteristics in various
tissues and organs, including lungs (Lundin and Driscoll, 2012; Stappenbeck and Miyoshi,
2009). Identification of homogenous stem cell populations in the lung is a challenge since lung
encompasses approximately 40 different types of cells with distinct functions (Filby, 2012;
Kajstura et al., 2011).There has been increasing evidence showing lung stem cells with selfrenewal and differentiation capability in mouse models, based on unique combinations of
specific cell surface marker profiles (Raiser and Kim, 2009; Stripp BR, 2011). Studies have
demonstrated that lung cells expressing Sca-1 were predominantly found in distal regions of
lungs and were shown to possess a temporal emergence, indicated by enrichment of Sca-1
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expressing cells in adult mouse lungs when compared to neonatal lungs (McQualter et al., 2009).
These Sca-1pos lung subpopulations established from adult mice lungs were shown to possess
stem cell characteristics of self-renewal and differentiation. Based on the expression of Sca-1 and
other markers, various studies have identified unique subpopulations in adult lung that possess
stem cell characteristics (Hegab et al., 2010). Thus Sca-1 emerged as a representative cell surface
marker to identify the lung stem cells. An important area of research is the identification of novel
cell surface markers that would aid in distinguishing lung stem cells and progenitor cells as well
as to isolate a homogenous population of these cells. Identification of endogenous lung stem
cells and progenitors not only aids in a fundamental understanding of lung biology, but also can
contribute to applications in regenerative medicine for treating lung diseases such as pulmonary
hypertension and chronic obstructive pulmonary diseases (Lau et al., 2012; Weiss, 2014).

Isolation of a subpopulation from the bone marrow based on expression of both Sca-1 and an
early mesodermal marker platelet-derived growth factor receptor α (PDGFRα) has enabled to
establish homogenous population of mesenchymal stem cells with minimum contamination of
hematopoietic stem cells and other cells (Morikawa et al., 2009). Lung is comprised of different
stem cell subpopulations with characteristics that differ with respect to the method of isolation
and choice of cell surface (Raiser and Kim, 2009). Recent evidences points to existence of
epithelial lung stem cells in Sca-1neg subpopulations and mesenchymal lung stem cells in Sca-1pos
subpopulation (Hegab et al., 2010; McQualter et al., 2009). Our rationale to characterize Plateletderived growth factor receptor-alpha (PDGFR-α) expression in lung cells was based on studies in
bone marrow (Houlihan et al., 2012) and heart (Chong et al., 2013) which supports its role as a
potential mesenchymal stem cell marker. In this study, we have characterized lung stem cells
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based on expression of Sca-1 and PDGFR-α cell surface markers. We hypothesize that lung cells
consist of subpopulations that differentially express PDGFR-α and Sca-1 with different stem cell
characteristics of self-renewal and differentiation. Here, we report for the first time,
morphological, phenotypical, and functional differences of subpopulations that point to a role for
PDGFR- α in sorting for subpopulations with defined stem cell characteristics and to further
determining its importance in the context of lung cancer.

3.3
3.3.1

Materials and methods
Lung isolation, enzymatic digestion, and cell sorting

For the purpose of this study, lungs (n=2) were dissected from p53+/+ Wild type C57BL/6
following the steps described (Gadepalli et al., 2013; Hegab et al., 2010). Briefly, the mice were
anesthetized by intra-peritoneal (IP) route and sacrificed by cervical dislocation. Careful
dissection is performed from posterior to anterior end of the abdomen to locate trachea near
throat region. 1 ml of dispase (2U/ml) is injected after a slight incision made on trachea.
Following the injection of dispase, the inflated lungs were carefully harvested along with trachea
and other visceral organs. The lung lobes were separated from the other body parts and incubated
in sterile solution containing dispase and collagenase to obtain slurry of the lung tissue
(Gadepalli et al., 2013). Finally, the red blood cells (RBC) and undigested lung tissue were
separated by addition of RBC lysis buffer, rinsing in sterile PBS++ (with Mg2+ and Ca2+) and
filtering through 0.45 µm sterile filter. The cells are counted and plated at 1000 cells per cm2 and
expanded for 21 days.
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Figure 3-1: Schematic representation of lung isolation, digestion, and cell sorting.
(i) Separation of lung lobes, mincing lung tissue, and enzymatic digestion to prepare single cell
suspension. (ii) RBC lysis and filtration of undigested lung tissue. (iii) Rinsing in growth
medium, cell counting and plating in appropriate tissue culture-treated flask. (iv) Collection of
single cells in trypsin, neutralize with growth medium and PBS++ wash. (v) Fluorescent
conjugated Antibody staining with appropriate controls, depletion of PE positive cells and FACS
sorting of lung subpopulations differentially expressing Sca-1 PDGFR-α. (vi) Propagating cells
in growth medium for downstream cell analysis.
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3.3.2

Cell culture components

As the current study aims to establish and characterize primary cells with stem cell
characteristics following similar marker combination reported by (Hegab et al., 2010), we opted
to use the same medium composition that was shown to be conducive for propagating these cells.
The components for growth medium are 10% defined FBS (HyClone Laboratories, Logan, Utah
USA), DMEM-High glucose with Glutamine & sodium pyruvate 1x Penicillin/Streptomycin, 1x
NEAA. Splitting of cells was carried at near confluence with 0.25% trypsin. Cryopreserved cell
stocks were prepared at regular passages using freezing medium containing 10% DMSO and
30% defined FBS. All reagents were obtained from Life Technologies (Grand Island, NY, USA)
unless otherwise noted.

3.3.3

FACS sorting and analysis of cell surface marker expression

The goal of the study is to establish lung stem/progenitor cell lines from mice with different p53
genetic background, based on expression of cell surface marker Sca-1 and PDGFR-α. For this
purpose, the cells were passaged using 0.25% trypsin, washed with PBS++ and suspended in 100
µl volume of PBS++ with respective concentration of conjugated antibody for staining, as
described in
Appendix i). The cells were incubated on ice for 30 minutes and washed twice with PBS++.
Sorting of the stained cells is performed on BSC Aria- BD FACSAria™ II High-Speed Cell
Sorter at flow cytometry shared resource, VCU. For the current study, first lineage CD45 and
CD31 positive lung cells were depleted and a 4-way gating was applied to sort Sca-1High
PDGFR-α High, Sca-1High PDGFR-α Low, Sca-1 Low PDGFR-α High, and Sca-1 Low PDGFR-α Low
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subpopulations of lung cells. All the sorting procedures were conducted under sterile conditions
and respective fluorophore isotype IgG control were employed as negative control.
For analysis of differential expression of Sca-1and PDGFR-α expression across the different p53
background mice, single cell suspension were obtained as described earlier and unsorted cells
were plated in 100 cm dish (in replicates). At near confluence, the uniform staining protocol was
employed as described in
Appendix i). The expression differences were evaluated on BD Accuri™ C6 flow cytometry (BD
Biosciences, Franklin Lakes, NJ, USA). For this purpose, equal numbers of flow events were
collected across all the samples in this study in replicates. Analysis was carried out using
respective fluorophore isotype controls. Statistical differences were assessed using Students t-test
and p-value <0.05 was considered significant.

3.3.4

AlamarBlue® cell proliferation assay

The differences in propagation for Sca-1 and PDGFR-α expressing lung subpopulations were
determined by AlamarBlue® Cell viability (Life Technologies, Grand Island, NY, USA). In this
study, to determine cell growth over a period of 7 days, the respective subpopulations were
trypsin passaged at confluence and cell counts were determined on BD Accuri™ C6 (BD
Biosciences, Franklin Lakes, NJ, USA), as describe in
Appendix ii). 500 cells were plated per well in a 96-well plate in quadruplicates for respective
lung cell lines. After allowing the cells to attach to the tissue culture plate for 4 hours the
medium is aspirated and a fresh growth medium mixed with 10% AlamarBlue® reagent was
added. Absorbance was measured at a wavelength of 570 nm and 600 nm using Synergy H1
plate reader. Continuous readings were obtained every day for a period of 7 days without
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changing the growth medium. Wells with growth medium alone and growth medium plus 10%
AlamarBlue® reagent were run as blanks. The experiment was repeated at two different passages
and OD readings were averaged across the experiments. The percent reduction of AlamarBlue®
reagent is calculated by the following equation,
AR570=�A570-(A600×Ro)�×100
Where,
AR570 = Amount of reduced AlamarBlue® reagent
A570 & A600 are sample absorbance at respective wavelength minus media blank
Ro = Correction factor. This is calculated by AO 570 ÷ AO 600, where AO 570 and AO 600 are
the Absorbance of Oxidized (AO) form of AlamarBlue® reagent, at respective wavelengths. AO
= OD 10% AlamarBlue® in medium - OD growth medium, at respective wavelengths.
3.3.5

Mesenchymal lineage differentiation analysis

The multipotent differentiation capability of the lung subpopulations established based on
differential expression of Sca-1 and PDGFR-α was evaluated by their ability to differentiate into
osteogenic and adipogenic lineage. For osteogenic differentiation, 10,000 cells were plated per
well of a 12-well tissue culture plate in growth medium. At 70 % confluence, the growth medium
is replaced with osteogenic differentiation medium containing 10nM Dexamethasone, 50 µM LAscorbic acid 2-phosphate and 20mM ß-Glycerophosphate disodium salt hydrate. The cells were
propagated for a period of 14-21 days. At the end of the differentiation period, the cells were
fixed with 4% Paraformaldehyde. The deposition of calcium was detected with 40 mM Alizarin
red stain. For adipogenic differentiation, 20,000 cells were plated per well of a 12-well tissue
culture plate in adipogenic differentiation medium containing 1:50,000 dilution of 1mM insulin
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and 1:10,000 dilution of 10 µM T3. At 100 % confluence, the differentiation medium is replaced
with adipogenic induction medium containing 0.125M Indomethacin, 2mg/ml dexamethasone,
0.25M IBMX along with 1mM insulin and 10 µM T3. The cells were induced in the induction
medium for 2 days and later maintained in adipogenic differentiation medium for 5 more days.
At the end of differentiation, the cells were fixed in 10% formaldehyde. The formation of lipid
droplets was detected with Oil Red O staining solution. Further details of the differentiation
protocol and staining procedure are described in Appendix iii. All reagents were obtained from
Sigma (St. Louis, MO, USA) unless otherwise noted.

3.3.6

RNA Isolation, real time reverse transcription polymerase chain reaction, and gene
expression analysis.

To quantitate expression of genes of interest listed in Appendix iv, cell pellets were collected and
RNA purification was performed using AllPrep DNA/RNA Mini Kit following manufacturer
instructions (Qiagen, Valencia, CA, USA). The RNA concentration of the samples was
determined by Nanodrop 2000c spectrophotometer (Thermo scientific, Wilmington, DE, USA)
and 1µg of RNA across all the sorted cell lines was converted into cDNA using High-Capacity
cDNA Reverse Transcription Kit (Life Technologies, Grand Island, NY, USA ). Q-PCR reaction
was setup using iTaq Universal SYBR Green supermix (BioRad, Hercules, CA, USA) with
appropriate concentration of primer and cDNA. The primer efficiencies of the internal control
(GAPDH) and genes of interest were determined by a standard curve. Gene expression data (in
triplicates) were acquired using CFX 96 real time system (C1000 touch). Details of the q-PCR
setup and protocol are described in
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Appendix v). GAPDH was run as a housekeeping reference gene and analysis was performed by
normalizing the expression quantity of gene of interest to the expression quantity of internal
control gene using the relative standard curve method (Livak and Schmittgen, 2001; Schmittgen
and Livak, 2008). Statistical significance was determined by Student t-test, with p-value <0.05
being considered as significantly different.

3.4
3.4.1

Results
Lung comprises of subpopulation of cells that differentially express Sca-1 and
PDGFR-α

In a single marker strategy to identify stem cells in the lung, Sca-1pos and linneg (CD31, CD45)
multipotent lung stem cells constitute subpopulations of cells that are heterogeneous (Hegab et
al., 2010). Various studies support the existence of more than one population of cells in tissues
with high cell turnover or regeneration (Barker et al., 2010). More importantly, as widely
elucidated in the hematopoietic system, distinguishing somatic stem and progenitor cells is
important to understand their role in tissue homeostasis and repair. Here, we evaluated the
characteristics of lung cells that differentially express Sca-1 and PDGFR-α post depletion of
CD45 and CD31expressing cells. Although a previous study has reported expression of PDGFRα in lung cells (McQualter et al., 2009), isolation and characterization of lung cells differentially
Sca-1 and PDGFR-α has not been studied.

Our results indicate that lung cells comprise of subpopulations of cells that differentially express
Sca-1 & PDGFR-α. We noted that after depleting the CD45posCD31pos cells, the percentage of
cells expressing Sca-1High PDGFR-αHigh constitute around 23.2% of the total population, Sca79
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1High PDGFR-αLow constitute 5%, while Sca-1Low PDGFR-α High and Sca-1Low PDGFR-αLow
constitute 28.5% and 26.3% respectively (Figure 3-2). In sorting based on single cell surface
marker Sca-1, Sca-1 High expressing lung subpopulations consists of small spindle shaped cells
mixed with large elongated cells. While sorting based on both Sca-1& PDGFR-α, lung
subpopulations are more homogenous. Subpopulations expressing Sca-1High and either high or
low expression of PDGFR-α constitute small spindle shaped cells. On the other hand,
subpopulations expressing in Sca-1Low and either high or low expression of PDGFR-α constitute
large elongated cells (Figure 3-3) , additional qPCR analysis of the sorted subpopulations
indicated representative expression of Sca-1 and PDGFR-α mRNA transcript levels (Figure 3-4).
We further evaluated the percentage of subpopulations expressing Sca-1 and PDGFR-α in
unsorted lung cells from p53 knock-in mice and compared them to those isolated from p53+/+
wild type mice. Our results from flow cytometry analysis indicate that lung cells from p53
knock-in mutants, p53R172H/+ and p53QSH/+, possess significant higher percentage (~3 fold
increase) of subpopulations expressing Sca-1High PDGFR-αHigh compared to those from p53+/+
wild type mice (Figure 3-5). Interestingly, Sca-1HighPDGFR-αLow, Sca-1LowPDGFR-αLow
subpopulations are significantly lower in lung cells isolated from p53 mutant knock-in mice.
These results demonstrate the potential for use of PDGFR-α as an important cell surface marker
to identify novel subpopulations in the lung.
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Figure 3-2: FACS sorting of lung cells differentially expressing Sca-1 & PDGFR-α
FACS sorting is performed with appropriate gating to deplete lineage positive cells (CD45 and
CD31) from single cell suspension prepared from the whole lung harvested from normal mice.
The remaining lung cell subpopulations were sorted for cells expressing both Sca-1, PDGFR-α
cell surface marker and plated in tissue culture dish for propagation.
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Figure 3-3: Subpopulations established based on both Sca-1& PDGFR-α expression
consists of homogenous cells.
Sorted lung subpopulations were plated in tissue culture dish and images were captured (scale
bar 100 µm). (A) In sorting based on single cell surface marker Sca-1, Sca-1 High expressing lung
subpopulations consists of small spindle shaped cells mixed with large elongated cells. (B) In
sorting based on both Sca-1& PDGFR-α, Sca-1High PDGFR-α expressing ( left) lung
subpopulations are more homogenous with spindle shaped cells while and Sca-1Low PDGFR-α
expressing are large elongated cells.
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Figure 3-4: Lung subpopulations established based on Sca-1& PDGFR-α expression show
representative Sca-1 and PDGFR-α mRNA transcript levels
Q-PCR analysis of relative transcript levels of Sca-1 and PDGFR-α across the lung
subpopulations established based on Sca-1, PDGFR-α cell surface marker expression. Results are
presented together with standard deviation from experiment conducted in triplicates.
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Figure 3-5: Sca-1High PDGFR-αHigh expressing lung subpopulations are significantly
increased in mice carrying p53 point mutations.
Unsorted lung cells established across different p53 background were propagated in culture and
cells differentially expressing both Sca-1, PDGFR-α (CD140-a) were analyzed by flow
cytometry. (A) Scatter plots of unsorted cells stained with Sca-1-FITC (x-axis) and PDGFR-α (yaxis) (B) Bar plots show significant differences in percentage of cells expressing Sca-1, PDGFRα between the p53 backgrounds. (* = p < 0.05). Results are presented together with standard
deviation from 3 independent cultures.
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3.4.2

Sca-1Low PDGFR-αHigh expressing lung subpopulation show higher proliferation

Under the in vitro culture conditions adopted in this study, we noted that these subpopulations
exhibit proliferation differences, with the Sca-1LowPDGFR-α High subpopulation exhibiting higher
proliferation capability (Figure 3-8). Given that PDGFR-α is a mesenchymal lineage marker, it is
expected that the subpopulations possess higher proliferation ability. Similarly, Sca1HighPDGFR-α High exhibit similar proliferation capabilities. We subsequently evaluated the
expression levels of N-cadherin mRNA levels, a mesenchymal marker, in the different
subpopulations. Our results indicate that the Sca-1LowPDGFR-α High subpopulation exhibit
significantly higher levels of N-cadherin when compared to all other sorted subpopulations
(Figure 3-7). Additionally, the Sca-1LowPDGFR-α High subpopulation expressed higher levels of
BMI-1 transcript levels, indicating the higher self-renewal potential of these cells (Figure 3-6).
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Figure 3-6: Sca-1Low PDGFR-αHigh expressing lung subpopulation show higher BMI-1
transcript levels
Q-PCR analysis of relative transcript levels of BMI-1 across the lung subpopulations sorted
based on Sca-1 and PDGFR-α cell surface marker expression. Sca-1LowPDGFR-αHigh
subpopulations exhibit higher BMI-1 transcript levels, indicative of higher proliferation and selfrenewal potential. Results are presented together with standard deviation from experiment
conducted in triplicates.
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Figure 3-7: Sca-1LowPDGFR-αHigh expressing lung subpopulation exhibit higher N-cadherin
mRNA expression
Q-PCR analysis of relative transcript levels of N-cadherin across the lung subpopulations
established based on Sca-1 and PDGFR-α cell surface marker expression. Sca-1LowPDGFR-αHigh
subpopulation exhibits higher N-cadherin transcript levels indicating its mesenchymal nature.
Results are presented together with standard deviation from experiment conducted in triplicates.
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Figure 3-8 PDGFR-α expressing lung subpopulation exhibit higher proliferation potential
The sorted cells are plated at 500 cells per well in 96 well plate, and the percentage reduction of
Alamar blue was measured by absorbance at 570 nm. Sca-1LowPDGFR-αHigh subpopulation
exhibit higher proliferation rate when compared with the other sorted subpopulations. Results are
presented together with standard deviation from two independent experiments conducted in
quadruplicates.
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3.4.3

Sca-1LowPDGFR-αHigh expressing lung subpopulation exhibit no differentiation
ability

Stem cells are characterized by their dual ability of self-renewal and differentiation into specific
lineages. Demonstrating the differentiation capability after repeated passages in culture is critical
in order to fully validate the stem cell characteristics of any derived cell line. In our study, after
repeated passages in culture, we evaluated the differentiation potential of early and late passage
cells to form adipocytes and osteocytes. Our results suggest that except for Sca-1LowPDGFR-α
High

subpopulation, all the sorted subpopulations possess adipogenic differentiation capabilities at

early and late passages, demonstrated by positive Oil Red O staining (Figure 3-9 & Figure 3-10).
In establishing lung stem/progenitor cells by use of Sca-1 alone, we noted that Sca-1High cells
readily differentiate to adipocytes while Sca-1Low cells do not. In the 2-way sorting strategy, with
Sca-1 & PDGFR-α, we did not observe any differentiation potential in Sca-1LowPDGFR-αHigh
cells, while Sca-1HighPDGFR-αLow and Sca-1LowPDGFR-αLow cells exhibited robust
differentiation.

Based on calcium deposition by Alizarin Red S staining, we observed a passage number effect
with early passage cells exhibiting osteogenic differentiation potential, while late passage cells
do not (Figure 3-11 and Figure 3-12). It is useful to note that the sorted subpopulations exhibit
similar osteogenic and adipogenic differentiation potentials. In single marker isolation using Sca1, Sca-1High cells readily differentiated when compared to Sca-1Low cells. In the 2-way sorting
strategy, with Sca-1 & PDGFR-α, we did not observe any osteogenic differentiation potential in
Sca-1LowPDGFR-α High lung subpopulation, while Sca-1HighPDGFR-α Low and Sca-1LowPDGFR-α
Low

cells exhibited robust differentiation.
89
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Figure 3-9: Sca-1High expressing lung subpopulation show higher adipogenic differentiation
The sorted cell lines established based on differential Sca-1 expression from normal mice were
propagated in adipogenic differentiation medium for 10 days. Adipogenesis was indicated by
formation of lipid vacuoles that stain with oil red o stain at the end of differentiation period. The
Sca-1High wild type lines show distinct oil red droplet formation compared to the Sca-1Low lung
subpopulation.
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Figure 3-10: Sca-1Low PDGFR-αHigh expressing lung subpopulation lack adipogenic
differentiation potential
The sorted cell lines established based on differential expression of both Sca-1 and PDGFR-α
were propagated in adipogenic differentiation medium for 10 days. Adipogenesis was indicated
by formation of lipid vacuoles that stain with Oil red O stain at the end of differentiation period.
The Sca-1HighPDGFR-αLow subpopulation exhibit robust adipogenic differentiation capacity,
while the Sca-1LowPDGFR-αHigh lung subpopulation lack adipogenic differentiation potential.
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Figure 3-11: Sca-1High expressing lung subpopulations demonstrate higher osteogenic
differentiation potential
The sorted cell lines established based on differential Sca-1 expression from normal mice were
propagated in osteogenic differentiation medium for 21 days. Osteogenesis was indicated by
deposition of calcium that stain with Alizarin red S at the end of the differentiation period. The
Sca-1High wild type lines show distinct Alizarin red S staining compared to Sca-1Low lung
subpopulation.
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Figure 3-12: Sca-1Low PDGFR-αHigh expressing lung subpopulation lack osteogenic
differentiation potential
The sorted cell lines established based on differential expression of both Sca-1 and PDGFR-α
were propagated in osteogenic differentiation medium for 21 days. Osteogenesis was indicated
by deposition of calcium that stain with Alizarin red S at the end of differentiation period. The
Sca-1HighPDGFR-αLow and Sca-1HighPDGFR-αHigh subpopulations exhibit robust osteogenic
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differentiation potential, while the Sca-1LowPDGFR-αHigh lung subpopulation lacks osteogenic
differentiation potential.
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3.5

Discussion

In this study, we adopted a two-marker strategy for isolation and characterization of multipotent
stem cells from the mouse lung. Our results support the existence of a heterogeneous lung cell
population, validating the recent evidence of multiple stem cell niches in the lung (Otto, 2002;
Raiser and Kim, 2009). Complex tissues like the lung, although primarily epithelial in nature are
believed to encompass both epithelial and mesenchymal stem cells (Slack, 2000; Stripp BR,
2011). Currently, functional assays to distinguish subpopulations with stem cell characteristics in
lungs is solely based on in vitro assays, that capture self-renewal and multipotent differentiation
potential. For instance, Bronchioalveolar Stem Cells (BASCs) identified by expression of Sca1posCD34pos, were characterized as epithelial lung stem cells (Kim et al., 2005), but another
systematic analysis of the same subpopulation classify them as fibroblastic given that these cells
also co-express Thy-1 and platelet-derived growth factor receptor α (PDGFR- α) (McQualter et
al., 2009). The discrepancy in the results between independent research groups was ascribed to
isolation methods, gating strategies, and culture conditions (Hegab et al., 2010; McQualter et al.,
2009; Raiser and Kim, 2009; Teisanu et al., 2009). Existence of heterogeneous stem cell
populations is not limited to the lung tissue alone with studies indicating co-existence of
hematopoietic and mesenchymal stem cells in the bone marrow (Morikawa et al., 2009; Wilson
and Trumpp, 2006). Identification of pure population of mesenchymal stem cells in bone marrow
was achieved by employing Sca-1 and PDGFR-α cell surface markers, where Sca-1posPDGFRαpos subpopulation was characterized as a homogenous population of mesenchymal stem cells
(Houlihan et al., 2012; Morikawa et al., 2009). Our analysis of differential expression of Sca-1
and PDGFR-α shows the potential role of PDGFR-α as a stem cell marker in the lung tissue.
Interestingly, our results indicate that the Sca-1LowPDGFR-αHigh lung cell subpopulation lack
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mesenchymal differentiation potential into adipocytes and osteocytes. The results suggests that
Sca-1posCD31negCD45neg lung cells comprise of cells that lack stem cell characteristics that can
be further purified based on differential expression of PDGFR-α. In contrast to the results found
in the bone marrow (Houlihan et al., 2012), the Sca-1HighPDGFR-αHigh, Sca-1HighPDGFR-αLow,
and Sca-1LowPDGFR-αLow subpopulations from the lung exhibit mesenchymal differentiation
potential. As expected, the Sca-1HighPDGFR-αHigh subpopulation exhibited high N-cadherin
expression and higher proliferation indicating its mesenchymal nature. Our results thus indicate
the potential role of PDGFR-α as a stem cell marker in lungs. We acknowledge the limited
functional assays to systematically discern these subpopulations as stem and progenitor cells,
thus indicating a need for development of more comprehensive experimentation to identify
hierarchy of stem cell populations in lung (Lau et al., 2012; McQualter et al., 2009; Raiser and
Kim, 2009). Developing in vitro assays that capture the in vivo conditions, lineage tracking and
single cell transplantation studies are required to assess the ability of putative lung stem and
progenitor cells in maintaining lung homeostasis and repair.

Vast majority of human cancers carry mutations in p53, most commonly point mutations in one
(p53mt/+) or both (p53mt/mt) p53 alleles (Lane, 1992; Lundin and Driscoll, 2012). These mutations
result in expression of mutant p53 proteins that contribute to tumorigenesis either by inhibition
of the wild type p53 activity or gain of function activities (Muller et al., 2011; Olive et al., 2004;
Vaughan et al., 2012a). Mutation in p53 results in selective effects on the function of p53 protein
thereby changing the phenotype of normal cells into cancerous nature. Advances in study of
cancer stem cells (CSCs) across different tissues has allowed to identify putative cell surface
markers that these cells express that contributes to distinguishing cancer stem cells from normal
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cells (Klonisch et al., 2008). In our study, we investigated the expression of Sca-1 and PDGFR-α
in lung population established from p53 mutants and p53+/+ wild type knock-in mice. The mice
carrying point mutants p53R172H/+ and p53QSH/+, exhibited a ~ 3 fold increase in subpopulation of
cells expressing Sca-1HighPDGFR-αHigh when compared with those isolated and propagated from
p53+/+ wild type mice. Interestingly, Sca-1HighPDGFR-αLow subpopulation is higher in unsorted
cells established from p53+/+ wild type mice and significantly lower in cells isolated from p53
mutant mice. This shift in the subpopulations expressing putative stem cells markers, Sca-1 and
PDGFR-α, indicates the potential effect of the p53 point mutations on the phenotype. Further
characterization of Sca-1 and PDGFR-α expressing lung subpopulation in these cancer sensitized
p53 mutants is thus required to establish PDGFR-α as a possible cancer stem cell marker.

In summary, our results presented here suggest the importance of PDGFR-α as an important
marker to sort out putative stem cells and progenitor cells from a heterogeneous lung tissue that
comprises of multiple stem cell niches. Moreover, our results demonstrate an increase in Sca1High PDGFR-αHigh subpopulation in lungs isolated from cancer sensitized p53 mutants,
indicating the potential use of PDGFR- α in sorting for subpopulations with defined stem cell
characteristics and to further determining its importance in the context of lung cancer.
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CHAPTER 4: CONCLUSIONS AND FUTURE DIRECTIONS

4.1
4.1.1

Conclusions
Chapter 2

Identifying somatic stem cells in various tissues has significantly progressed in the past decade,
with use of specific cell surface markers to isolate resident stem cells that contribute to
regeneration. Similar advancements in understanding lung biology have paved the way to
identify and characterize lung stem/progenitor cells with multipotent differentiation potential.
Unlike rapidly self-renewing tissues/organs like intestine, skin, and bone marrow, lung tissue
does not exhibit high regenerative ability. However, identification and isolation of prospective
lung stem/progenitor cells is of enormous interest given the increasing evidence of cancer stem
cells in numerous tissue types. Given that lung cancer is the leading cause of cancer related
mortality, identification and characterization of somatic lung stem cells not only aides in
understanding the biology of the lung, but also in treating lung related disorders.
In this study, we aimed to investigate the characteristics of Sca-1 expressing subpopulations
isolated from cancer sensitized p53 mutant (p53R172H/+ & p53QSH/+) mice and compared with their
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counterparts isolated from p53+/+ wild type mice. Based on different experimental outcomes, we
arrived at the following conclusions:
•

Direct comparisons of phase contrast images demonstrate that the Sca-1High and Sca-1Low
subpopulations from p53+/+ wild type comprise of a heterogeneous population. However,
the same subpopulations isolated from cancer sensitized p53R172H/+ & p53QSH/+ mutant
mice possess homogenous cells with prominent mesenchymal characteristics.

•

Cancer sensitized p53R172H/+ & p53QSH/+ mutant mice possess a significantly higher
percentage of Sca-1High lung subpopulations, when compared with cell isolated from
p53+/+ wild type mice. Comparisons within the two mutants indicate that the cells isolated
from the p53R172H/+ knock-in mice possess a higher percentage of Sca-1High cells.

•

Cell lines isolated from p53R172H/+ & p53QSH/+ knock-in mice possess a higher colony
forming ability at low seeding density and higher BMI-1 expression indicating their selfrenewal potential.

•

Cell lines generated from cancer sensitized p53 backgrounds exhibited a higher
proliferation and self-renewal potential than those isolated from p53+/+ wild type mice.

•

Cell lines isolated from p53R172H/+ & p53QSH/+ knock-in mice demonstrated tumorigenic
characteristics when compared to cell lines isolated from p53+/+ wild type mice as
determined by:
o Sca-1High and Sca-1Low subpopulations from p53R172H/+ background show a higher
migration rate.
o Sca-1High subpopulations from both p53R172H/+ & p53QSH/+ mutant backgrounds
exhibited a significant colony formation in anchorage-independent growth
conditions.
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o Sca-1Low subpopulations from p53R172H/+ mice exhibited a significant colony
formation in anchorage-independent growth conditions. However, Sca-1Low
subpopulations from p53QSH/+ mice did not exhibit significant colony formation in
anchorage-independent growth conditions.
o Sca-1High and Sca-1Low subpopulations from p53QSH/+ mice express an
accumulation of p53 protein, indicating that aberrant p53 protein is expressed in
these cells.
o Subpopulations from p53R172H/+ knock-in mice showed significant tumorigenic
properties but did not show any p53 accumulation.
•

Both Sca-1High and Sca-1Low subpopulations from the p53+/+ wild type mice exhibit
differentiation potential when differentiated into osteogenic and adipogenic lineage,
while Sca-1High subpopulations showed more homogenous differentiation ability
compared to the Sca-1Low subpopulation.

•

Subpopulations isolated from cancer sensitized p53 mutants did not show any adipogenic
differentiation. However, Sca-1Low subpopulation from mutant mice showed scarce
osteogenic differentiation.

•

To further understand the potential role of p53 in regulating Sca-1 and PDGFR-α we
performed Ingenuity pathway analysis, based on peer reviewed published interaction
data. We observed that, p53 regulates the expression of Sca-1 and PDGFR-α, which
probably, explains the increase in Sca-1and PDGFR-α expression in lung cell lines that
carry p53 point mutations. Our analysis also shows a direct interaction between p53 and
BMI-1 inside the nucleus (Figure 4-1). Based on the Ingenuity pathway interaction data,
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it is reasonable to expect that point mutations in p53 resulted in increased expression of
Sca-1, PDGFR-α and BMI-1 genes.
•

Our current data supports low differentiation potential of lung sub-populations carrying
p53 point mutations. Hence, we investigated if p53 regulates any genes that are involved
in mesenchymal lineage differentiation. The process of adipocyte differentiation is tightly
regulated by a number of transcription factors, hormones and signaling pathway
molecules(Rosen and MacDougald, 2006). Adipogenesis from pre-adipocytes into mature
adipocyte is precisely coordinated by transcription factors such as CCAAT-enhancerbinding proteins (C/EBPs) and peroxisome proliferator-activated receptor γ (PPARγ),
cytokines, and hormones(Wu et al., 1999). Based on ingenuity analysis, we noted that
p53 inhibits the expression of PPARγ, an important transcription factor in adipogenesis.
We hypothesize that as a result of p53 point mutations, cellular accumulation of p53
could occur and inhibit PPARγ, thereby resulting in loss of cells during the differentiation
process and lack of differentiation further (Figure 4-1).
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Figure 4-1: Possible role of p53 in regulating expression of genes investigated in this study
Using ingenuity pathway analysis, the role of p53 in regulating gene expression of Sca-1,
PDGFR-α, BMI-1, and PPARG were analyzed. Known relationships based on ingenuity
database are designated on line connectors. (A) Activation, (E) Expression, (I) Inhibition, (P)
Phosphorylation, (PP) Protein-Protein interaction, (UB) Ubiquitination, (L) Molecular cleavage.
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4.1.2

Chapter 3

Our current understanding of resident lung stem cells is not comprehensive. The distinction
between adult stem cells and progenitor cells is still an area of active research. The lung is a
complex organ comprised of different types of cells with distinct functionalities and it is thus
important to tease apart these differences both in vitro and in vivo. Various research studies have
indicated the existence of mesenchymal and epithelial stem cells in the lung, but identifying cell
surface markers that homogenously identify these populations is still a research question. Here,
for the first time we have isolated and characterized lung cells differentially expressing two cell
surface markers Sca-1 and PDGFR-α in p53+/+ wild type mice with the goal to identify and
characterize a pure population of mesenchymal lung stem cells. We compared the characteristics
of these subpopulations with those lung cells that were isolated based on Sca-1High and Sca-1Low
only expression. Our results obtained from different experiments conducted in this study support
the following conclusions:
•

Existence of different subpopulations in the lung that express Sca-1 and PDGFR-α.

•

Lung cells expressing Sca-1LowPDGFR-αHigh and Sca-1HighPDGFR-αHigh
subpopulations constitute cells with higher proliferation capabilities.

•

Sca-1LowPDGFR-αHigh subpopulation exhibit a higher BMI-1 expression and a higher
N-cadherin expression, indicating their proliferating and mesenchymal nature.

•

Sca-1LowPDGFR-αHigh subpopulation lack adipogenic and osteogenic differentiation
potential.

•

Even though all other subpopulations show adipogenic and osteogenic differentiation
potential, Sca-1HighPDGFR-αLow and Sca-1HighPDGFR-αHigh subpopulations exhibit
more robust differentiation capabilities.
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•

Increase in Sca-1HighPDGFR-αHigh subpopulation in lungs isolated from cancer
sensitized p53 mutants.

•

Based on our preliminary results, PDGFR-α is a potential marker in sorting for
subpopulations with defined stem cell characteristics.

4.2
4.2.1

Future directions
Chapter 2

Our results suggest that subpopulations isolated and propagated from cancer-sensitized p53
mutants show distinct tumorigenic properties such as a high migration rate, high proliferation,
and colony formation in non-adherent culture conditions. Our preliminary results suggests that
these cells show limited mesenchymal differentiation potential compared to those cells derived
from wild type mice. We propose to further test the differentiation potential of these cells into
different lung lineages and hypothesize that Sca-1High cells from p53 mutant mice possess
unipotent rather than multipotent differentiation potential. Based on the outcome of this studies,
we will also test the ability of Sca-1High cancer-sensitized cells to induce tumor formation in
immune compromised mice. This could be achieved by the following specific aims:
Specific aim 1: Characterize Sca-1 expressing lung cells from p53 mutant mice for their
differentiation ability to other lung lineages.
The goal of this specific aim is to characterize and compare the lineage specific differentiation
capability of Sca-1 expressing lung cells. We will first investigate the expression of lung lineage
specific genes in the sorted lungs by Q-PCR and immuno-staining. Based on these results, we
will further subject the subpopulations to differentiation medium for lung endothelial and
epithelial cell types, specifically into alveolar type I, II, and clara cells. We will compare and
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quantitate the differentiation capability and assess the self-renewal ability by assaying lineagespecific marker expression with Q-PCR and Western blot analysis. We expect that results from
this specific aim will assist in further evaluating the stem cell characteristics of specific
subpopulations from cancer sensitized mice.
Specific aim 2: Determining the tumor-propagating ability of Sca-1 sorted cells across cancersensitized p53 mutant genotypes.
The goal of this specific aim is to establish the cancerous nature of putative lung stem cells in
vivo. For this purpose, we will first investigate the expression of known cancer stem cell markers
in these subpopulations by flow cytometry and conduct gene expression studies by Q-PCR. We
will further transplant these Sca-1 expressing cells into NOD/SCID immune-deficient mice to
investigate their proliferation and self-renewal nature in vivo by lineage labelling strategy. We
expect that Sca-1 cells isolated from the p53 mutant mice will form a tumor and metastasize.

4.2.2

Chapter 3

The two-marker strategy to identify lung stem cells in this study supports the existence of Sca1Low PDGFR-αHigh subpopulation with no differentiation capability. Our preliminary results
points to the potential role of PDGFR-α as a stem cell marker in the lung. We propose to test the
significant role of PDGFR-α expressing cells by characterizing the sorted cells for their ability to
differentiate into various lung lineages. We will further characterize the ability of these
subpopulations to maintain long-term self-renewal and assess their role in lung repair. We
speculate that results from the following specific aims will assist in enhancing our knowledge of
lung biology, by delineating long-term self-renewing lung stem cells from the short term selfrenewing progenitor cells.
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Specific aim 1: To evaluate long-term self-renewal potential of putative lung stem cells
identified by PDGFR-α and Sca-1 expression
It is important to understand the long-term self-renewal nature of lung cells differentially
expressing Sca-1 and PDGFR-α. For this purpose, we will test the differentiation potential of
these subpopulations over a time period of early and late passages. To ascertain both selfrenewal and differentiation potential of these cells, we will select colonies obtained from a single
cell and induce differentiation. We will test the long-term differentiation potential of these cells
into clara cells (epithelial), adipocytes (mesenchymal), and bronchiolar (endothelial) lineages
across early and late passages. We will further quantitate the expression of respective lineage
markers at the end of the differentiation period. The results from this specific aim will help to
distinguish differences in long-term self-renewal potential of these subpopulations, which will
shed some light on uni- and multi-potent differentiation capabilities of these subpopulations.

Specific aim 2: To evaluate the regeneration ability of the Sca-1 and PDGFR-α cells in mice
models of lung injury
In order to identify the role of Sca-1 and PDGFR-α expressing lung subpopulation in turnover
and repair after injury, we propose to study mouse models of lung injury (naphthalene) that
specifically depletes clara cell population. This will be achieved by a lineage labelling strategy
that can track the subpopulations in vivo. The results from these in vitro and in vivo studies that
investigate the regeneration potential of sorted subpopulations will aide us in better
understanding the putative lung stem cell populations expressing Sca-1 and PDGFR-α.
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APPENDIX

Appendix i: Conjugated antibodies list

Antibody

Sca-1FITC

FITC
Isotype
Ctrl

Bio-legend
10810
Catalog #
400505
5
Stock Conc.( µg) 50
50
Total volume
100
100
(µl)
Stock
0.5
0.5
Conc.(mg/ml)

PDGFR-α
-APC

APCIsotype
Ctrl

Company

Working Conc.

CD 31PE

CD45RAPE

BD Pharmigen
135907

135907

561073

551402

25

25

25

100

125

125

125

500

0.2

0.2

0.2

0.2

1 µg per Million cells in 100 µl volume

Volume required
2 µl
from stock

2 µl

5 µl

5 µl

5 µl

5 µl

Appendix ii: Cell Counting with BD Accuri ™ C6

1. Trypsin passage cells at confluence
2. Centrifuge and discard the trypsin medium. Re-suspend the pellet in 1 ml of fresh growth
medium.
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3. Aliquot 100 µl of the cell suspension into 0.5 ml centrifuge tubes and run through BD
Accuri™ C6 flow cytometer.
4. Flow run settings: Run 50 µl of respective sample, at a
Medium fluidics speed. Plot FSC-Area vs SSC-Area (as
in example image) to gate the healthy cell population.
Note the number of events in the healthy gate.
5. Divide the number events by volume run on flow (Ex:
10000 events/50 µl i.e. 200 events/ cells per µl) to obtain events or cell number per µl.
Extrapolate to the total volume the cells are suspended in to get the total cell number.
(900 µl * 200 = 180,000 cells)
6. Prepare a working cell suspension of 50,000 cells per 1 ml. (Ex: 250 µl of cell suspension
in 750 µl of fresh growth medium.
7. Add required number of cells for respective experiment.
8. NOTE: For larger pellets increase the re-suspension volume to avoid clumping.
9. Triturate the cell suspension repeatedly before running through the flow cytometer.
Avoid bubbles.

Appendix iii: Differentiation and staining protocol

Adipogenic differentiation medium: DMEM High Glucose 1x (Gibco Cat# 11965-092), 10%
FBS (Hyclone Cat# SH30070.03), 1x Penicillin/Streptomycin (Life Technologies Cat# 15140-
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122), 1:50,000 dilution of 1mM insulin (Sigma Cat#I2643) and 1:10,000 dilution of 10 µM T3
(Sigma Cat# T-2877).
Adipogenic induction medium: To the complete adipogenic differentiation medium, add 0.125M
Indomethacin ( Sigma Cat# I-7378), 2mg/ml dexamethasone (Sigma cat# D2915), 0.25M IBMX
( Sigma Cat# I-5879) along with 1mM insulin ( Sigma Cat#I2643) and 10 µM T3 ( Sigma Cat#
T-2877). (Prepare it fresh for every use). Note: For proper dissolution indomethacin and IBMX
should be heated to 75 C before adding to medium.
Osteogenic differentiation medium: MEM 1x (Gibco Cat# 11090-081), 10% FBS (Hyclone Cat#
SH30070.03), 1x Penicillin/Streptomycin (Life Technologies Cat# 15140-122), L-Glutamine (
Gibco Cat# 25030081) with 10nM Dexamethasone (Sigma Cat# D2915), 50 µM L-Ascorbic acid
2-phosphate (Sigma Cat# A8960) and 20mM ß-Glycerophosphate disodium salt hydrate (Sigma
Cat# G9422).
Oil Red O Stain: To prepare stock solution, dissolve 0.5 g of Oil Red O powder (Santa Cruz
Biotech, Cat# SC-203749) in 100 ml of isopropanol. The solution can be stored up to 3 months.
For working solution, dilute 3 ml of stock solution in 2 ml of de-ionized water and filter it
through Whatman Grade 1 filter paper. Prepare working solution fresh as per need.
Alizarin Red S Stain: Dissolve 1.369 g of Alizarin Red S ( Santa Cruz Biotech, Cat# 205998) in
100 ml of distilled water. After complete dissolution the pH should be around 4.2. If not, adjust
the pH using Ammonium hydroxide. The solution could be stored up to 3 months.
Adipogenic differentiation and staining
Day 1: Plate cells on a tissue culture plate at 5000 cells per cm2 in adipogenic differentiation
medium.
Day 2: Allow cells to grow 100 % confluence.
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Day 3: Allow cells to grow 100 % confluence.
Day 4: If the cells are 100 % confluent, then aspirate the medium and replace fresh adipogenic
induction medium.
Day 5: Do not disturb the cells.
Day 6: Gently replace the induction medium with adipogenic differentiation medium.
Day 7: Do not disturb the cells.
Day 8: Gently replace medium with fresh Adipogenic differentiation medium.
Day 9: Do not disturb the cells.
Day 10: Visible oil droplets should be noted at this point. Capture bright field images of the oil
droplets.
NOTE: As the adipogenic differentiation progress the cells tend to detach from the surface.
Hence, be gentle in movement, medium changes and washes.
Oil Red O Staining: Replace growth medium and wash the cells with PBS++
1. Fix the cells with 10% (v/v) formaldehyde (Sigma Cat# F8775) prepared in PBS++ and
incubate at room temperature for 20 minutes.
2. Replace the fixative agent with freshly prepared Oil Red O working solution. Make sure
the working solution is filtered properly. Incubate at room temperature for 1 hr.
3. Rinse the plates 2 to 3 times with di H20 to remove excess stain or precipitate.
4. Dry the plates. Visualize and capture images of the stained monolayers.
Osteogenic differentiation and staining
1. Plate cells on a tissue culture plate at 2500 cells per cm2 in MLSC growth medium.
2. Allow cells to grow 70 % confluence.
3. Replace the medium with osteogenic differentiation medium.
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4. Allow the cells to propagate for 14-21 days with medium replacement on every alternate
day.
5. Monitor the cells for calcification mineral deposition. Capture images using an inverted
microscope.
Membrane Alkaline Phosphatase (AP) staining: After 7 days in osteogenic differentiation
medium the cells can be tested for expression of membrane alkaline phosphatase. For this
purpose, wash the cells with PBS++, fix them in 4% (w/v) PFA for 10 minutes and appropriate
volume of BCIP/NPT staining solution (Sigma B3804) is added. The plates are covered and
incubated for 20-30 minutes at room temperature. Visible blue (low AP expression) to dark
purple (high AP expression) color staining is observed at the end of incubation.
Alizarin Red S (ARS) Stain: After the 14 days of differentiation period
1. Wash the cells in di H20.
2. Fix the cells in 10% (v/v) formaldehyde (Sigma Cat# F8775) prepared in di H20.
3. Wash twice in di H20, add appropriate volume of ARS stain and incubate the plates at
room temperature for 1 hour.
4. Wash the plates 2-3 times with di H20 until the stain precipitate is aspirated out.
5. Visualize and capture images of the stained monolayers.
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Appendix iv: Primer list
Gene ID
12250
12258

Gene Name

Direction Sequence

GC %

Mouse-Ecadherin
Mouse Ncadherin

Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

57.1
52.4
47.6
55
52.4
43.5
52.4
57.9
50
43.5
47.6
52.4
47.6
57.1
52.4
45.5
43.5
52.2
47.6
52.6

12151

Mouse BMI-1

14433

Mouse GAPDH

71950

Mouse-Nanog

110454

Mouse Sca-1

18595

Mouse PDGFR-α

648

Human BMI-1

5460

Human-Oct4

2597

Human-GAPDH

caggtctcctcatggctttgc
cttccgaaaagaaggctgtcc
atagcccggtttcacttgaga
caggctttgatccctctgga
cttgctggtctccaagtaacg
aaatccccacttaatgtgtgtcc
aggtcggtgtgaacggatttg
ggggtcgttgatggcaaca
cacagtttgcctagttctgagg
gcaagaatagttctcgggatgaa
gaggcagcagttattgtggat
cgttgaccttagtacccagga
atgagagtgagatcgaaggca
cggcaaggtatgatggcagag
ccacctgatgtgtgtgctttg
ttcagtagtggtctggtcttgt
gggagattgataactggtgtgtt
gtgtatatcccagggtgatcctc
ttgccatcaatgaccccttca
cgccccacttgattttgga

Product
length
175
160
118
95
87
112
130
162
144
174

Appendix v: RNA extraction, cDNA and Q-PCR reaction setup

RNA/ DNA Extraction
1. Plate 5000 cells per cm2 in 60 mm dish and propagate until confluence.
2. Collect the cells in trypsin, quench trypsin action in growth medium and wash the cells
with PBS++.
3. Pellet the cells by centrifuging at 1000 rpm for 4 minutes and aspirate PBS++, without
disturbing the pellet.
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4. Snap freeze the pelleted cells in liquid nitrogen for 10 seconds. The cells could be stored
at -80 c until ready for RNA extraction.
5. Extract RNA and DNA using the AllPrep DNA/RNA Mini Kit (Qiagen Cat# 80204).
6. After extraction measure the quantity of RNA and DNA using nano drop 2000.
7. Dilute RNA to 100 ng/µl and proceed to cDNA synthesis step
8. Dilute DNA to 10 ng/ul and proceed to Genotyping step.

cDNA synthesis reaction setup
PCR Reaction
Setup
10x RT Buffer
25x dNTP Mix
100mM
10xRT Random
Primer
Reverse
Transcriptase
Nuclease Free H20
100 ng/ul RNA
Total volume

Stock
Conc.
10

per 20
µl Rxn
2

Final
Conc.
1

100

0.8

4

10

2

1

10

1

0.5

100

4.2
10
20

50

Cycling Step
Incubation
RT reaction
Enzyme
Inactivation
Storage

5 min at 85
End at 4 C
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Temperature
& Time
10 min at 25
120 min at 37
C

Q-PCR reaction setup
PCR Reaction
Setup
2x SybrGreen Mix
dd H20
Total volume
5uM Forward
primer
5uM Reverse
primer
1 ng/µl cDNA
Total volume

Stock
Conc.
2

per 25
µl Rxn
12.5
5.5
18

Final
Conc.
1

5

1

0.2

5

1

0.2

1

5
7

0.2

Temperature
& Time
Polymerase
10 min at 95
Activation
C
Denaturation
15 sec at 95 C
Annealing/Extension 30 sec at 58.5
Cycling Step

Cycles

40
Cycles

Standard PCR reaction setup
PCR Reaction
Setup
10x PCR buffer
10uM Forward
primer
10uM Reverse
primer
500 Units Taq Pol
dd H20
50 ng/µl DNA
Total volume

Stock
Conc.
10

per 20
µl Rxn
2

10

0.4

10

0.4

500

0.4
13.8
3
20

50
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Final
Conc.
1
0.2
0.2
10
7.5

Cycling Step

Temperature
& Time

Initial denaturation
Denaturation
Annealing
Extension

10 min at 95
C
30 sec at 95 C
30 sec at 56.5
45 sec at 72 C

Final Extension

4 min at 72 C

Cycles

1
34
Cycles
1

Agarose gel preparation
•

Dissolve 2g of ultra-pure agarose in 100 ml of TAE buffer. Heat until agarose dissolves
into solution. Let it cool to about 50 C

•

Add 6 µl of ethidium bromide carefully and stir under the exhaust hood. Pour the solution
into a gel tray and let it cool. Once gel is formed, carefully pull the comb without
breaking the gel.

•

Mix 20 µl of PCR end-product with 4 µl loading dye and add it to wells. Load
appropriate gel ladder in one well. Run the gel at 100 V for about 1 -2 hours.

•

Capture images of the bands under a gel dock reader.
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Appendix vi: BCIP-AP staining in negative control
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Appendix vii: Migration assay on Sca-1High and Sca-1Low subpopulations across different
p53 backgrounds
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Appendix viii Immunoblotting (Western Blot)
1. Sample preparation
•

Cells must be confluent and ready to be harvested from a 60mm cell culture plate.

•

Use the total protein extraction kit which has 50x Protease inhibitor cocktail + TM lysis
buffer (with NP40). Make 1x Protease inhibitor by diluting it from 50x using lysis buffer.

•

Wash the cell plate with PBS after aspirating the media out. Be careful not to leave any
traces of media in the plate as this will obstruct viewing the protein of interest on SDS
PAGE later on.

•

Use ice cold PBS and cold tubes for the rest of the sample preparation.

•

Trypsinize the cells and spin them down.

•

Wash the cell pellet with PBS.

•

Add 100 μl of lysis buffer to 1 million cells.

•

Pipette it up and down.

•

Tape the tubes down to a vortex and keep it on constant agitation at 4°C for 30 minutes.

•

Centrifuge at 13000 g at 4°C for 15-20 minutes.

•

Collect the supernatant and dump the pellet. The supernatant is the protein.

2. Protein concentration: BSA assay
•

Dye reagent (5x)

•

BSA lyophilized powder

•

Add 20 ml water to do the BSA powder and mix it to get a 1.44 mg/ml protein solution.

•

Make three dilutions of protein solution (0.2 mg/ml, 0.4 mg/ml, 0.8 mg/ml).
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•

0.8 mg/ml: 1.44 mg – 1ml

•

0.8 mg – 0.8/1.44 = 0.556 ml

•

Add 0.444 ml dd H2O

•

109

•

1ml of 0.8 mg/ml solution

•

0.4 mg/ml: Take 0.5 ml of 0.8 mg/ml and add 0.5 ml of dd H2O to get 1 ml of 0.4 mg/ml
solution.

•

0.2 mg/ml: Make 1ml of protein solution in the same way as above.

•

Dye reagent: 1 part of 5x dye + 4 parts water = 25 ml dye (1x)

•

Pour the dye reagent through a Whatman filter paper.

•

Take 20 μl of protein (standards/sample) for 1ml of dye reagent and vortex it properly
and incubate it for 5min at room temperature.

•

Perform spectrophotometric analysis at 595nm to get the OD values.

•

Only 30 μg of protein per well in gel. Do the calculations and take the required amount of
protein sample and make up the volume to 30 μl using laemmli buffer (1:1 or 1:2).

•

Before using the laemmli buffer, it is required to add β-mercaptoethanol to the laemmli
buffer.

•

Add 50 μl β-mercaptoethanol to 950 μl Laemmli buffer and mix it well.

•

Add 1:1 ratio of Laemmli buffer to protein sample.

•

Boil water on a burner, parafilm-seal the lids of the eppendorf tubes that contain sample
and place the samples in boiling water for around 10 minutes.

•

Spin them down to the bottom of the tube.
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3. Running SDS PAGE
•

Making running buffer: Take 900ml ddH2O in a glass bottle and add 100ml of TrisGlycine-SDS and mix it well.

•

Once the samples and buffers are ready, take them near the running apparatus.

•

Get the gel ready from 4°C and take the tape off the bottom of the gel.

•

Place it carefully in the gel holder and make sure to place the gel in a way that the wells
are facing inside. Balance the other side using another gel if you are running two gels at
the same time or use a dam to seal the other end.

•

Pour running buffer into the gel holder to check if it is sealed well.

•

Once it is established that there are no leaks, go ahead and take the comb out of the wells
and saturate it with running buffer.

•

Load ladder and samples carefully into the respective wells without releasing air bubbles
into the well from the pipette.

•

Run at 20mA for around 45min or till the protein reaches the bottom of the gel. Be
careful not to let the protein run out from the bottom of the gel. If the gel has run well, the
ladder is well separated.

4. Transfer onto nitrocellulose membrane
•

Preparation: While the SDS PAGE is still running, get the transfer buffer ready and store
it at 4°C.

•

Take 700 ml water, 100 ml tris-glycine, 200 ml methanol and mix it well.

•

Take ice in white ice-holder and fill it with a little water and keep it at -20°C until use.
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•

Cut the required size of the nitrocellulose and be careful not to touch without gloves and
hold it using forceps. Place it in some transfer buffer.

•

Wet the sponges and filter paper in the transfer buffer as well.

•

Once the gel is run, carefully break open the gel case without breaking the gel.

•

Place the nitrocellulose on gel supported by a filter paper.

•

Let the gel come onto the membrane and then place another filter paper on gel.

•

Press them smoothly and now place sponges on either side and roll a Pasteur pipette on
this sandwich tightly to get rid of bubbles. (IMPORTANT)

•

Do not forget the gel side and the membrane side.

•

Black side: Gel

•

Clear side: Nitrocellulose membrane

•

Clear side should go next to red and black side onto black and back goes back. Place the
other sandwich with another set of gel-membrane or plain sponges.

•

Place the ice pack in the apparatus and place the whole apparatus in a trough containing
ice.

•

Now pour the cold transfer buffer into the apparatus and run it at 90V for around 1 hour
15 min-30min.

•

You know the transfer has begun once you notice bubbles rising up from the bottom.

•

The transfer is successful when the ladder is perfectly visible on the nitrocellulose
membrane.

5. Blocking and washes:
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•

Use 3% block solution or make 5% block using nonfat casein powder in TBS-Tween
solution

•

TBS-Tween: 900ml water, 100ml TBS, 1ml Tween-20

•

Do a 10 min wash with TBS-Tween.

•

Primary and Secondary Antibodies:

•

Make the primary antibody solution in 0.1% TBS-Tween solution (15ml). It can be
reused when stored at 4°C.

•

Add it to the washed membrane and leave it overnight at 4°C with constant agitation or
upto 2 hrs. at room temperature with stirring.

•

Do 3x 10 min washes with TBS-Tween.

•

Make secondary antibody in TBS-Tween (10ml).

•

Add it onto membrane and leave it on stirring for 1 hour.

•

Do not reuse the secondary antibody solution. Do 3x 10 min washes with TBS-Tween
and detect using the Odyssey Infrared Imaging System (Li-Cor Biosciences, NE).
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